US20120215163A1 - Sensing systems and methods - Google Patents
Sensing systems and methods Download PDFInfo
- Publication number
- US20120215163A1 US20120215163A1 US13/462,752 US201213462752A US2012215163A1 US 20120215163 A1 US20120215163 A1 US 20120215163A1 US 201213462752 A US201213462752 A US 201213462752A US 2012215163 A1 US2012215163 A1 US 2012215163A1
- Authority
- US
- United States
- Prior art keywords
- housing portion
- fluidic media
- fluid conduit
- electrical contacts
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01B—MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
- G01B7/00—Measuring arrangements characterised by the use of electric or magnetic techniques
- G01B7/14—Measuring arrangements characterised by the use of electric or magnetic techniques for measuring distance or clearance between spaced objects or spaced apertures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1413—Modular systems comprising interconnecting elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/162—Needle sets, i.e. connections by puncture between reservoir and tube ; Connections between reservoir and tube
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R3/00—Apparatus or processes specially adapted for the manufacture or maintenance of measuring instruments, e.g. of probe tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M2005/14268—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body with a reusable and a disposable component
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1585—Needle inserters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1072—Tube connectors; Tube couplings with a septum present in the connector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/14—Detection of the presence or absence of a tube, a connector or a container in an apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1456—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49002—Electrical device making
- Y10T29/49117—Conductor or circuit manufacturing
- Y10T29/49204—Contact or terminal manufacturing
- Y10T29/49208—Contact or terminal manufacturing by assembling plural parts
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Abstract
A fluidic media detection system for detecting a presence of fluidic media includes a first housing portion adapted to be carried by a user; a second housing portion configured to be selectively operatively engaged with and disengaged from the first housing portion, the second housing portion for supporting a reservoir having an interior volume for containing fluidic media; a fluid conduit supported by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged; and at least one interactive element, positioned near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.
Description
- This application relates to and claims priority from U.S. Provisional Application 61/561,801, filed Nov. 18, 2011, incorporated herein by reference in its entirety. This application is a Continuation-In-Part of U.S. application Ser. No. 12/650,287, filed Dec. 30, 2009, incorporated herein by reference in its entirety. This application is a Continuation-In-Part of U.S. application Ser. No. 12/650,378, filed Dec. 30, 2009, incorporated herein by reference in its entirety. This application is a Continuation-In-Part of U.S. application Ser. No. 13/235,288, filed Sep. 16, 2011, incorporated herein by reference in its entirety.
- 1. Field
- Embodiments of the present invention relate generally to medical device systems and methods and, in specific embodiments, to systems and methods for detecting alignment, connection, and/or positioning of components of medical devices.
- 2. Related Art
- According to modern medical techniques, certain chronic diseases may be treated by delivering a medication or other substance to the body of a patient. For example, diabetes is a chronic disease that is commonly treated by delivering defined amounts of insulin to a patient at appropriate times. Traditionally, manually operated syringes and insulin pens have been employed for delivering insulin to a patient. More recently, modern systems have been designed to include programmable pumps for delivering controlled amounts of medication to a patient.
- Pump type delivery devices have been configured in external devices, which connect to a patient, and have been configured in implantable devices, which are implanted inside of the body of a patient. External pump type delivery devices include devices designed for use in a stationary location, such as a hospital, a clinic, or the like, and further include devices configured for ambulatory or portable use, such as devices designed to be carried by a patient, or the like. External pump-type delivery devices may contain reservoirs of fluidic media, such as, but is not limited to, insulin.
- External pump-type delivery devices may be connected in fluid flow communication to a patient or user-patient, for example, through suitable hollow tubing. The hollow tubing may be connected to a hollow needle that is designed to pierce the skin of the patient and to deliver fluidic media there through. Alternatively, the hollow tubing may be connected directly to the patient as through a cannula, or the like.
- Examples of some external pump type delivery devices are described in U.S. patent application Ser. No. 11/211,095, filed Aug. 23, 2005, titled “Infusion Device And Method With Disposable Portion” and Published PCT Application WO 01/70307 (PCT/US01/09139) titled “Exchangeable Electronic Cards For Infusion Devices” (each of which is owned by the assignee of the present invention), Published PCT Application WO 04/030716 (PCT/US2003/028769) titled “Components And Methods For Patient Infusion Device,” Published PCT Application WO 04/030717 (PCT/US2003/029019) titled “Dispenser Components And Methods For Infusion Device,” U.S. Patent Application Publication No. 2005/0065760 titled “Method For Advising Patients Concerning Doses Of Insulin,” and U.S. Pat. No. 6,589,229 titled “Wearable Self-Contained Drug Infusion Device,” each of which is incorporated herein by reference in its entirety.
- External pump-type delivery devices may be connected in fluid-flow communication to a patient-user, for example, through suitable hollow tubing. The hollow tubing may be connected to a hollow needle that is designed to pierce the patient-user's skin and deliver an infusion medium to the patient-user. Alternatively, the hollow tubing may be connected directly to the patient-user as or through a cannula or set of micro-needles.
- In contexts in which the hollow tubing is connected to the patient-user through a hollow needle that pierces skin of the user-patient, a manual insertion of the needle into the patient-user can be somewhat traumatic to the user-patient. Accordingly, insertion mechanisms have been made to assist the insertion of a needle into the user-patient, whereby a needle is forced by a spring to move quickly from a retracted position into an extended position. As the needle is moved into the extended position, the needle is quickly forced through the skin of the user-patient in a single, relatively abrupt motion that can be less traumatic to certain user-patients as compared to a slower, manual insertion of a needle. While a quick thrust of the needle into the skin of the user-patient may be less traumatic to some user-patients than a manual insertion, it is believed that, in some contexts, some user-patients may feel less trauma if the needle is moved a very slow, steady pace.
- Examples of insertion mechanisms that may be used with and may be built into a delivery device are described in: U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, titled “Infusion Medium Delivery system, Device And Method With Needle Inserter And Needle Inserter Device And Method,”; and U.S. patent application Ser. No. 11/211,095, filed Aug. 23, 2005, titled “Infusion Device And Method With Disposable Portion” (each of which is assigned to the assignee of the present invention), each of which is incorporated herein by reference in its entirety. Other examples of insertion tools are described in U.S. Patent Application Publication No. 2002/0022855, titled “Insertion Device For An Insertion Set And Method Of Using The Same” (assigned to the assignee of the present invention), which is incorporated herein by reference in its entirety. Other examples of needle/cannula insertion tools that may be used (or modified for use) to insert a needle and/or cannula, are described in, for example U.S. patent application Ser. No. 10/389,132 filed Mar. 14, 2003, and entitled “Auto Insertion Device For Silhouette Or Similar Products,” and/or U.S. patent application Ser. No. 10/314,653 filed Dec. 9, 2002, and entitled “Insertion Device For Insertion Set and Method of Using the Same,” both of which are incorporated herein by reference in their entirety. Further examples of various insertion tools are described in, but are not limited to, U.S. patent application Ser. No. 11/645,972, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,052, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,000, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method,” all of which are herein incorporated by reference in their entirety.
- Pump-type delivery devices can allow accurate doses of insulin to be calculated and delivered automatically to a patient-user at any time during the day or night. Furthermore, when used in conjunction with glucose sensors or monitors, insulin pumps may be automatically controlled to provide appropriate doses of infusion medium at appropriate times of need, based on sensed or monitored levels of blood glucose.
- Pump-type delivery devices have become an important aspect of modern medical treatments of various types of medical conditions, such as diabetes. As pump technologies improve and as doctors and patient-users become more familiar with such devices, the popularity of external medical infusion pump treatment increases and is expected to increase substantially over the next decade.
- A fluidic media detection system for detecting a presence of fluidic media includes (but is not limited to) a first housing portion, a second housing portion, a fluid conduit, and at least one interactive element. The first housing portion is adapted to be carried by a user. The second housing portion is configured to be selectively operatively engaged with and disengaged from the first housing portion. The second housing portion for supporting a reservoir having an interior volume for containing fluidic media. The fluid conduit supported by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged. The at least one interactive element positioned near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.
- In various embodiments, the fluid conduit comprises a cannula for insertion into the skin of the user to allow the fluidic media to flow into the body of the user.
- In various embodiments, the fluid conduit provides fluid communication between the reservoir and a cannula for insertion into the skin of the user to allow the fluidic media to flow into the body of the user.
- In various embodiments, the fluid conduit is supported by the first housing portion.
- In various embodiments, the at least one interactive element comprises at least one sensor arranged to detect a parameter or the characteristic of the fluidic media when the fluidic media is in the fluid conduit. The at least one sensor configured to provide an output signal indicating that the fluidic media is detected in the fluid conduit.
- In some embodiments, the system further includes an indication device controlled by the output signal to notify the user when fluidic media is detected.
- In some embodiments, the indicator device produces one of an audible and tactical feedback when fluidic media is detected.
- In various embodiments, the at least one interactive element comprises at least one electrical component configured to detect a change in at least one electrical characteristic of the fluid conduit or the fluidic media when the fluidic media is present in the fluid conduit. The at least one electrical component configured to provide an output signal indicating that the fluidic media is detected in the fluid conduit
- In various embodiments, the at least one interactive element comprises at least one optical receiver configured to detect a change in light when the fluidic media is in the fluid conduit. The at least one optical receiver configured to provide an output signal indicating that fluidic media is detected in the fluid conduit.
- In various embodiments, the at least one interactive element comprises at least one reactive element, positioned near a portion of the fluid conduit, that reacts with at least one component within or characteristic of the fluidic media when the fluidic media is present in the fluid conduit.
- In some embodiments, the at least one reactive element comprises at least one chemical, positioned near the fluid conduit, that reacts with at least one component within the fluidic when the fluidic media is present in the fluid conduit.
- In further embodiments, a product of a chemical reaction, between the at least one chemical and the at least one component within the fluidic media, is a colored complex.
- In yet further embodiments, the system further includes an optical receiver configured to detect a change in light when the colored complex is created by the chemical reaction. The optical receiver configured to provide an output signal indicating that fluidic media is detected.
- In even further embodiments, the system further includes a light conducting element that guides light from a point near the fluid conduit to the optical receiver.
- In even further embodiments, the light conducting element is at least one fiber optic cable.
- In even further embodiments, wherein the light conducting element is a fluid connector in communication with the fluid conduit.
- In further embodiments, the at least one chemical is embedded in the fluid conduit.
- In further embodiments, the fluid conduit is impregnated with the at least one chemical.
- In various embodiments, the system further includes a rosette positioned near the fluid conduit. The at least one interactive element comprises at least one electrical component coupled to the rosette to detect a change in at least one electrical characteristic associated with the rosette when fluidic media is present in the fluid conduit.
- In some embodiments, the rosette is a closed circuit, such that impedance across the rosette decreases as fluidic media nears the fluid conduit.
- In some embodiments, the rosette is an open circuit, such that the circuit is closed when fluidic media nears the fluid conduit.
- In some embodiments, the at least one electrical component detects voltage across the rosette.
- In some embodiments, the at least one electrical component detects impedance across the rosette.
- In some embodiments, the at least one electrical component detects capacitance across the rosette.
- In some embodiments, the system further includes an indication device coupled to the electrical component to notify the user when fluidic media is detected.
- In further embodiments, the indicator device produces one of an audible and tactical feedback when fluidic media is detected.
- In some embodiments, the rosette surrounds an exterior surface of the fluid conduit. An interior surface of the fluid conduit is in contact with fluidic media when the fluidic media is in the fluid conduit.
- A method of manufacturing a fluidic media detection system for detecting a presence of fluidic media may include, but is not limited to, any one or combination of: (i) adapting a first housing portion to be carried by a user; (ii) configuring a second housing portion to be selectively operatively engaged with and disengaged from the first housing portion, the second housing portion for supporting a reservoir having an interior volume for containing fluidic media; (iii) supporting a fluid conduit by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged; and (iv) positioning at least one interactive element near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.
- A medical device for treating a user includes, but is not limited to, a first housing portion, a second housing portion, a plurality of electrical contacts, a shorting mechanism, a magnetic source, a sensor, and electronic circuitry. The first housing portion adapted to be carried by a user. The second housing portion configured to be selectively operatively engaged with and disengaged from the first housing portion. The plurality of electrical contacts provided on at least one of the first housing portion and the second housing portion. The plurality of electrical contacts includes a set of main electrical contacts and at least one other electrical contact. The shorting mechanism provided on the other of the first housing portion and the second housing portion. The shorting mechanism for interacting with the set of main electrical contacts. The magnetic source having at least one of a certain magnetic field and a certain magnetic strength provided on at least one of the first housing portion and the second housing portion. The sensor for detecting at least one of the certain magnetic field and the certain magnetic strength provided on the other of the first housing portion and the second housing portion. The electronic circuitry configured to provide a first signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the set of main electrical contacts of the plurality of electrical contacts. The electronic circuitry configured to provide a second signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts. The electronic circuitry configured to provide a first sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of the certain magnetic field and the certain magnetic strength of the magnetic source. The electronic circuitry configured to provide a second sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of a magnetic field different from the certain magnetic field and a magnetic strength different from the certain magnetic strength of the magnetic source.
- In various embodiments, the device further includes a user-perceptible indicator operatively coupled to the electronic circuitry for providing a user-perceptible indication in response to receiving one or more of the first signal, the second signal, the first sensing signal, and the second sensing signal.
- In some embodiments, the user-perceptible indication comprises at least one of an audible indication, a visual indication, and a tactile indication.
- In some embodiments, the user-perceptible indicator provides a first type of indication when the first sensing signal is received from the electronic circuitry and a second type of indication when at least one of the second signal and the second sensing signal is received from the electronic circuitry.
- In various embodiments, the device further includes a drive device supported by one of the first housing portion and the second housing portion, the drive device for selectively driving fluid from a reservoir. The delivery device further comprises control electronics operatively coupled to the electronic circuitry for controlling the drive device based upon receiving one or more of the signals from the electronic circuitry.
- In some embodiments, the control electronics is configured to inhibit operation of the drive device unless the first sensing signal is received.
- In some embodiments, the control electronics is configured to begin operation of the drive device upon receiving the first sensing signal.
- In some embodiments, the electronic circuitry configured to provide the first sensing signal for activating the control circuitry in a case where the sensor detects a gauss level exceeding a first pre-defined threshold value.
- In further embodiments, the sensor comprises a magnetic threshold switch.
- In various embodiments, the magnetic source has a certain magnetic field direction. The sensor for detecting the certain magnetic field direction. The electronic circuitry configured to provide the first sensing signal when the sensor detects the certain magnetic field direction.
- In some embodiments, the electronic circuitry configured to provide the second sensing signal when the sensor detects a magnetic field direction different from the certain magnetic field direction.
- In various embodiments, the certain magnetic field includes a direction, the sensor configured for detecting the direction.
- In some embodiments, the first signal causes the sensor to begin detecting the at least one of the certain magnetic field and the certain magnetic strength.
- In some embodiments, the set of main electrical contacts interact with the shorting mechanism when the shorting mechanism contacts the set of main electrical contacts. The electronic circuitry configured to provide the first signal when the shorting mechanism contacts the set of main electrical contacts of the plurality of electrical contacts. The electronic circuitry configured to provide the second signal when the shorting mechanism contacts the at least one other electrical contact of the plurality of electrical contacts.
- In various embodiments, the shorting mechanism has a plurality of ends. Each of the ends for interacting with a respective main electrical contact of the set of main electrical contacts. The electronic circuitry configured to provide the first signal when each of the ends of the shorting mechanism interacts with the respective main electrical contact of the set of main electrical contacts. The electronic circuitry configured to provide the second signal when at least one of the ends of the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts.
- In some embodiments, the set of main electrical contacts comprising a first main electrical contact and a second main electrical contact. The plurality of ends of the shorting mechanism including a first end and a second end for interacting with the first main electrical contact and the second main electrical contact. The electronic circuitry configured to provide the first signal when the first end and the second end of the shorting mechanism interacts with the first main electrical contact and the second main electrical contact of the plurality of electrical contacts. The electronic circuitry configured to provide the second signal when at least one of the first end and the second end of the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts.
- In various embodiments, at least one of the at least one other electrical contact is arranged between the set of main electrical contacts.
- In various embodiments, at least some of the set of main electrical contacts are arranged to be outermost electrical contacts of the plurality of electrical contacts.
- In various embodiments, all of the at least one other electrical contact is arranged in between the set of main electrical contacts.
- In various embodiments, the shorting mechanism is configured to establish an electrical connection between the set of main electrical contacts when the shorting mechanism interacts with the set of main electrical contacts.
- In various embodiments, the device further includes a fluid conduit and at least one interactive element. The fluid conduit supported by one of the first housing portion and the second housing portion in a position to engage a reservoir, supported by the other of the first housing portion and the second housing portion, to establish fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged. The at least one interactive element, positioned near a portion of the fluid conduit, interacts with the fluidic media when the fluidic media is present in the fluid conduit. The circuitry configured to provide a first positioning signal in a case where the first housing portion and the second housing portion are brought together and the at least one interactive element interacts with the fluidic media when the fluidic media is present in the fluid conduit.
- In some embodiments, the device further includes a drive device supported by one of the first housing portion and the second housing portion, the drive device for selectively driving fluidic media from the reservoir. The delivery device further comprises control electronics operatively coupled to the electronic circuitry for controlling the drive device based upon receiving one or more of the signals from the electronic circuitry.
- In further embodiments, the control electronics are configured to begin operation of the upon receiving the first positioning signal.
- A method of manufacturing a medical device for treating a user may include, but is not limited to, any one or combination of: (i) adapting a first housing portion to be carried by a user; (ii) configuring a second housing portion to be selectively operatively engaged with and disengaged from the first housing portion; (iii) providing a plurality of electrical contacts on at least one of the first housing portion and the second housing portion, the plurality of electrical contacts including a set of main electrical contacts and at least one other electrical contact; (iv) providing a shorting mechanism on the other of the first housing portion and the second housing portion, the shorting mechanism for interacting with the set of main electrical contacts; (v) providing a magnetic source having at least one of a certain magnetic field and a certain magnetic strength on at least one of the first housing portion and the second housing portion; (vi) providing a sensor for detecting at least one of the certain magnetic field and the certain magnetic strength on the other of the first housing portion and the second housing portion; (vii) configuring electronic circuitry to provide a first signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the set of main electrical contacts of the plurality of electrical contacts; (viii) configuring the electronic circuitry to provide a second signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts; (ix) configuring the electronic circuitry to provide a first sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of the certain magnetic field and the certain magnetic strength of the magnetic source; and (x) configuring the electronic circuitry to provide a second sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of a magnetic field different from the certain magnetic field and a magnetic strength different from the certain magnetic strength of the magnetic source.
-
FIG. 1 illustrates a generalized representation of a system in accordance with an embodiment of the present invention; -
FIG. 2 illustrates an example of a system in accordance with an embodiment of the present invention; -
FIG. 3 illustrates an example of a delivery device in accordance with an embodiment of the present invention; -
FIG. 4 illustrates a delivery device in accordance with an embodiment of the present invention; -
FIG. 5A illustrates a durable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 5B illustrates a section view of a durable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 5C illustrates a section view of a durable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 6A illustrates a disposable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 6B illustrates a section view of a disposable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 6C illustrates a section view of a disposable portion of a delivery device in accordance with an embodiment of the present invention; -
FIG. 7 illustrates portions of a medical device in accordance with an embodiment of the present invention; -
FIG. 8 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 9 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 10 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 11 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 12 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 13 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 14 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 15 illustrates a medical device in accordance with an embodiment of the present invention; -
FIG. 16 illustrates cross-section of a needle-inserting device in accordance with an embodiment of the present invention; -
FIGS. 17A-17C illustrate various rosettes in accordance with an embodiment of the present invention; -
FIGS. 18A-18C illustrate a portion of a medical device system in accordance with an embodiment of the present invention; -
FIG. 19 illustrates a portion of a medical device system in accordance with an embodiment of the present invention; -
FIGS. 20A and 20B illustrate a portion of a medical device system in accordance with an embodiment of the present invention; -
FIGS. 21A and 21B illustrate a portion of a medical device system in accordance with an embodiment of the present invention; -
FIGS. 22A and 22B illustrate a portion of a medical device system in accordance with an embodiment of the present invention; -
FIG. 23 illustrates a block diagram of an electrical configuration of a medical device system in accordance with an embodiment of the present invention; -
FIG. 24 illustrates an alignment verification process S2400 in accordance with an embodiment of the present invention; and -
FIG. 25 an alignment monitoring process S5400 in accordance with an embodiment of the present invention. -
FIG. 1 illustrates a generalized representation of asystem 10 in accordance with an embodiment of the present invention. Thesystem 10 may include adelivery device 12. Thesystem 10 may further include asensing device 14, a command control device (CCD) 16, and acomputer 18. In various embodiments, thedelivery device 12 and thesensing device 14 may be secured at desired locations on thebody 5 of a patient or user-patient 7. The locations at which thedelivery device 12 and thesensing device 14 are secured to thebody 5 of the user-patient 7 inFIG. 1 are provided only as representative, non-limiting, examples. - The
system 10, thedelivery device 12, thesensing device 14, theCCD 16, andcomputer 18 may be similar to those described in the following U.S. Patent Applications that were assigned to the assignee of the present invention, where each of following patent applications is incorporated herein by reference in its entirety: (i) U.S. patent application Ser. No. 11/211,095, filed Aug. 23, 2005, “Infusion Device And Method With Disposable Portion”; (ii) U.S. patent application Ser. No. 11/515,225, filed Sep. 1, 2006, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (iii) U.S. patent application Ser. No. 11/588,875, filed Oct. 27, 2006, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (iv) U.S. patent application Ser. No. 11/588,832, filed Oct. 27, 2006, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (v) U.S. patent application Ser. No. 11/588,847, filed Oct. 27, 2006, “Infusion Medium Delivery Device And Method With Compressible Or Curved Reservoir Or Conduit”; (vi) U.S. patent application Ser. No. 11/589,323, filed Oct. 27, 2006, “Infusion Pumps And Methods And Delivery Devices And Methods With Same”; (vii) U.S. patent application Ser. No. 11/602,173, filed Nov. 20, 2006, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (viii) U.S. patent application Seri. No. 11/602,052, filed Nov. 20, 2006, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (ix) U.S. patent application Ser. No. 11/602,428, filed Nov. 20, 2006, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (x) U.S. patent application Ser. No. 11/602,113, filed Nov. 20, 2006, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (xi) U.S. patent application Ser. No. 11/604,171, filed Nov. 22, 2006, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (xii) U.S. patent application Ser. No. 11/604,172, filed Nov. 22, 2006, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (xiii) U.S. patent application Ser. No. 11/606,703, filed Nov. 30, 2006, “Infusion Pumps And Methods And Delivery Devices And Methods With Same”; (xiv) U.S. patent application Ser. No. 11/606,836, filed Nov. 30, 2006, “Infusion Pumps And Methods And Delivery Devices And Methods With Same”; U.S. patent application Ser. No. 11/636,384, filed Dec. 08, 2006, “Infusion Medium Delivery Device And Method With Compressible Or Curved Reservoir Or Conduit”; (xv) U.S. patent application Ser. No. 11/645,993, filed Dec. 26, 2006, “Infusion Medium Delivery Device And Method With Compressible Or Curved Reservoir Or Conduit”; U.S. patent application Ser. No. 11/645,972, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xvi) U.S. patent application Ser. No. 11/646,052, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xvii) U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xviii) U.S. patent application Ser. No. 11/646,000, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xix) U.S. patent application Ser. No. 11/759,725, filed Jun. 7, 2007, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (xx) U.S. patent application Ser. No. 11/606,837, filed Nov. 30, 2006, “Method And Apparatus For Enhancing The Integrity Of An Implantable Sensor Device”; (xxi) U.S. patent application Ser. No. 11/702,713, filed Feb. 5, 2007, “Selective Potting For Controlled Failure And Electronic Devices Employing The Same”; (xxii) U.S. patent application Ser. No. 11/843,601, filed Aug. 22, 2007, “System And Method For Sensor Recalibration”; (xxiii) U.S. patent application Ser. No. 11/868,898, filed Oct. 8, 2007, “Multilayer Substrate”; (xxiv) U.S. patent application Ser. No. 11/964,649, filed Dec. 26, 2007, “System And Methods Allowing For Reservoir Air Bubble Management”; (xxv) U.S. patent application Ser. No. 12/111,751, filed Apr. 29, 2008, “Systems And Methods For Reservoir Filling”; (xxvi) U.S. patent application Ser. No. 12/111,815, filed Apr. 29, 2008, “Systems And Methods For Reservoir Air Bubble Management”; (xxvii) U.S. patent application Ser. No. 11/924,402, filed Oct. 25, 2007, “Sensor Substrate And Method Of Fabricating Same”; (xxviii) U.S. patent application Ser. No. 11/929,428, filed Oct. 30, 2007, “Telemetry System And Method With Variable Parameters”; (xxix) U.S. patent application Ser. No. 11/965,578, filed Dec. 27, 2007, “Reservoir Pressure Equalization Systems And Methods”; (xxx) U.S. patent application Ser. No. 12/107,580, filed Apr. 22, 2008, “Automative Filling Systems And Methods”; (xxxi) U.S. patent application Ser. No. 11/964,663, filed Dec. 26, 2007, “Medical Device With Full Options And Selective Enablement/Disablement”; (xxxii) U.S. patent application Ser. No. 10/180,732, filed Jun. 26, 2002, “Communication Station And Software For Interfacing With An Infusion Pump, Analyte Monitor, Analyte Meter, Or The Like”; (xxxiii) U.S. patent application Ser. No. 12/099,738, filed Apr. 8, 2008, “Systems And Methods Allowing For Reservoir Air Bubble Management”; (xxxiv) U.S. patent application Ser. No. 12/027,963, filed Feb. 7, 2008, “Adhesive Patch Systems And Methods”; (xxxv) U.S. patent application Ser. No. 12/121,647, filed May 15, 2008, “Multi-Lumen Catheter”; (xxxvi) U.S. Patent Provisional Application Ser. No. 61/044,269, filed Apr. 11, 2008, “Reservoir Plunger Head Systems And Methods”; (xxxvii) U.S. patent application Ser. No. 61/044,292, filed Apr. 11, 2008, “Reservoir Barrier Layer Systems And Methods”; (xxxviii) U.S. Patent Provisional Application Ser. No. 61/044,322, filed Apr. 11, 2008, “Reservoir Seal Retainer Systems And Methods”; (xxxix) U.S. patent application Ser. No. 12/179,502, filed Jul. 24, 2008, “Method For Formulating And Immobilizing A Matrix Protein And A Matrix Protein For Use In A Sensor”; (xl) U.S. patent application Ser. No. 12/336,367, filed Dec. 16, 2008, “Needle Insertions Systems And Methods”; (xli) U.S. patent application Ser. No. 12/166,210, filed Jul. 1, 2008, “Electronic Device For Controlled Failure”; (xlii) U.S. patent application Ser. No. 12/271,134, filed Nov. 14, 2008, “Multilayer Circuit Devices And Manufacturing Methods Using Electroplated Sacrificial Structures”; (xliii) U.S. patent application Ser. No. 12/171,971, filed Jul. 11, 2008, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xliv) U.S. patent application Ser. No. 12/189,077, filed Aug. 8, 2008, “Packaging System”; (xlv) U.S. patent application Ser. No. 12/179,536, filed Jul. 24, 2008, “Real Time Self-Adjusting Calibration Algorithm”; (xlvii) U.S. patent application Ser. No. 12/277,186, filed Nov. 24, 2008, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; (xlviii) U.S. patent application Ser. No. 12/211,783, filed Sep. 16, 2008, “Implantable Sensor Method And System”; (xlix) U.S. patent application Ser. No. 12/247,945, filed Oct. 8, 2008, “Infusion Medium Delivery Device And Method With Drive Device For Driving Plunger In Reservoir”; (1) U.S. patent application Ser. No. 12/360,077, filed Jan. 26, 2009, “Reservoir Barrier Layer Systems And Methods”; (1i) U.S. patent application Ser. No. 12/345,362, filed Dec. 29, 2008, “Reservoir Seal Retainer Systems And Methods”; (lii) U.S. patent application Ser. No. 12/353,181, filed Jan. 13, 2009, “Systems And Methods Allowing For Reservoir Filling And Infusion Medium Delivery”; (liii) U.S. patent application Ser. No. 12/360,813, filed Jan. 27, 2009, “Multi-Position Infusion Set Device And Process”; (liv) U.S. Patent Pub. No. US 2007/0142776 (application Ser. No. 10/314,653), filed Dec. 9, 2002, “Insertion Device For An Insertion Set and Methods Of Using The Same.” In other embodiments, thesystem 10,delivery device 12,sensing device 14,CCD 16, andcomputer 18 may have other suitable configurations. - The
delivery device 12 may be configured to deliver fluidic media to thebody 5 of the user-patient 7. In various embodiments, fluidic media may include a liquid, a fluid, a gel, or the like. In some embodiments, fluidic media may include a medicine or a drug for treating a disease or a medical condition. For example, fluidic media may include insulin for treating diabetes, or may include a drug for treating pain, cancer, a pulmonary disorder, HIV, or the like. In some embodiments, fluidic media may include a nutritional supplement, a dye, a tracing medium, a saline medium, a hydration medium, or the like. - The
sensing device 14 may include a sensor, a monitor, or the like, for providing sensor data or monitor data. In various embodiments, thesensing device 14 may be configured to sense a condition of the user-patient 7. For example, thesensing device 14 may include electronics and enzymes reactive to a biological condition, such as a blood glucose level, or the like, of the user-patient 7. - In various embodiments, the
sensing device 14 may be secured to thebody 5 of the user-patient 7 or embedded in thebody 5 of the user-patient 7 at a location that is remote from the location at which thedelivery device 12 is secured to thebody 5 of the user-patient 7. In various other embodiments, thesensing device 14 may be incorporated within thedelivery device 12. In other embodiments, thesensing device 14 may be separate and apart from the delivery device, and may be, for example, part of theCCD 16. In such embodiments, thesensing device 14 may be configured to receive a biological sample, analyte, or the like, to measure a condition of the user-patient 7. - In further embodiments, the
sensing device 14 and/or thedelivery device 12 may utilize a closed-loop system. Examples of sensing devices and/or delivery devices utilizing closed-loop systems may be found at, but are not limited to, the following references: (i) U.S. Pat. No. 6,088,608, entitled “Electrochemical Sensor And Integrity Tests Therefor”; (ii) U.S. Pat. No. 6,119,028, entitled “Implantable Enzyme-Based Monitoring Systems Having Improved Longevity Due To Improved Exterior Surfaces”; (iii) U.S. Pat. No. 6,589,229, entitled “Implantable Enzyme-Based Monitoring Systems Adapted for Long Term Use”; (iv) U.S. Pat. No. 6,740,072, entitled “System And Method For Providing Closed Loop Infusion Formulation Delivery”; (v) U.S. Pat. No. 6,827,702, entitled “Safety Limits For Closed-Loop Infusion Pump Control”; (vi) U.S. Pat. No. 7,323,142, entitled “Sensor Substrate And Method Of Fabricating Same”; (vii) U.S. patent application Ser. No. 09/360,342, filed Jul. 22, 1999, entitled “Substrate Sensor”; and (viii) U.S. Provisional patent application Ser. No. 60/318,060, filed Sep. 7, 2001, entitled “Sensing Apparatus and Process”, all of which are incorporated herein by reference in their entirety. - In such embodiments, the
sensing device 14 may be configured to sense a condition of the user-patient 7, such as, but not limited to, blood glucose level, or the like. Thedelivery device 12 may be configured to deliver fluidic media in response to the condition sensed by thesensing device 14. In turn, thesensing device 14 may continue to sense a new condition of the user-patient, allowing thedelivery device 12 to deliver fluidic media continuously in response to the new condition sensed by thesensing device 14 indefinitely. In some embodiments, thesensing device 14 and/or thedelivery device 12 may be configured to utilize the closed-loop system only for a portion of the day, for example only when the user-patient is asleep or awake. - Each of the
delivery device 12, thesensing device 14, theCCD 16, and thecomputer 18 may include transmitter, receiver, or transceiver electronics that allow for communication with other components of thesystem 10. Thesensing device 14 may be configured to transmit sensor data or monitor data to thedelivery device 12. Thesensing device 14 may also be configured to communicate with theCCD 16. Thedelivery device 12 may include electronics and software that are configured to analyze sensor data and to deliver fluidic media to thebody 5 of the user-patient 7 based on the sensor data and/or preprogrammed delivery routines. - The
CCD 16 and thecomputer 18 may include electronics and other components configured to perform processing, delivery routine storage, and to control thedelivery device 12. By including control functions in theCCD 16 and/or thecomputer 18, thedelivery device 12 may be made with more simplified electronics. However, in some embodiments, thedelivery device 12 may include all control functions, and may operate without theCCD 16 and thecomputer 18. In various embodiments, theCCD 16 may be a portable electronic device. In addition, in various embodiments, thedelivery device 12 and/or thesensing device 14 may be configured to transmit data to theCCD 16 and/or thecomputer 18 for display or processing of the data by theCCD 16 and/or thecomputer 18. - In some embodiments, the
sensing device 14 may be integrated into theCCD 16. Such embodiments may allow the user-patient to monitor a condition by providing, for example, a sample of his or her blood to thesensing device 14 to assess his or her condition. In some embodiments, thesensing device 14 and theCCD 16 may be for determining glucose levels in the blood and/or body fluids of the user-patient without the use of, or necessity of, a wire or cable connection between thedelivery device 12 and thesensing device 14 and/or theCCD 16. - In some embodiments, the
CCD 16 may be for providing information to the user-patient that facilitates the user-patient's subsequent use of a drug delivery system. For example, theCCD 16 may provide information to the user-patient to allow the user-patient to determine the rate or dose of medication to be administered into the body of the user-patient. In other embodiments, theCCD 16 may provide information to thedelivery device 12 to control the rate or dose of medication administered into the body of the user-patient - Examples of the types of communications and/or control capabilities, as well as device feature sets and/or program options may be found in the following references: (i) U.S. patent application Ser. No. 10/445,477, filed May 27, 2003, entitled “External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities”; (ii) U.S. patent application Ser. No. 10/429,385, filed May 5, 2003, entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same”; and (iii) U.S. patent application Ser. No. 09/813,660, filed Mar. 21, 2001, entitled “Control Tabs for Infusion Devices and Methods of Using the Same,” all of which are incorporated herein by reference in their entirety.
-
FIG. 2 illustrates an example of thesystem 10 in accordance with an embodiment of the present invention. Thesystem 10 in accordance with the embodiment illustrated inFIG. 2 includes thedelivery device 12 and thesensing device 14. Thedelivery device 12 in accordance with an embodiment of the present invention may include adisposable housing 20, adurable housing 30, and areservoir system 40. Thedelivery device 12 may further include aninfusion path 50. - Elements of the
delivery device 12 that ordinarily contact the body of a user-patient or that ordinarily contact fluidic media during operation of thedelivery device 12 may be considered as a disposable portion of thedelivery device 12. For example, a disposable portion of thedelivery device 12 may include thedisposable housing 20 and thereservoir system 40. The disposable portion of thedelivery device 12 may be recommended for disposal after a specified number of uses. - On the other hand, elements of the
delivery device 12 that do not ordinarily contact the body of the user-patient or fluidic media during operation of thedelivery device 12 may be considered as a durable portion of thedelivery device 12. For example, a durable portion of thedelivery device 12 may include thedurable housing 30, electronics (not shown inFIG. 2 ), a drive device having a motor and drive linkage (not shown inFIG. 2 ), and the like. Elements of the durable housing portion of thedelivery device 12 are typically not contaminated from contact with the user-patient or fluidic media during normal operation of thedelivery device 12 and, thus, may be retained for re-use with replaced disposable portions of thedelivery device 12. - In various embodiments, the
disposable housing 20 may support thereservoir system 40 and has a bottom surface (facing downward and into the page inFIG. 2 ) configured to secure to the body of the user-patient. An adhesive may be employed at an interface between the bottom surface of thedisposable housing 20 and the skin of the user-patient to adhere thedisposable housing 20 to the skin of the user-patient. In various embodiments, the adhesive may be provided on the bottom surface of thedisposable housing 20, with a peelable cover layer covering the adhesive material. In this manner, the cover layer may be peeled off to expose the adhesive material, and the adhesive side of thedisposable housing 20 may be placed against the user-patient, for example against the skin of the user-patient. Thus in some embodiments, thedelivery device 12 may be attached to the skin of the user-patient. - In other embodiments, the
disposable housing 20 and/or the remaining portions of thedelivery device 12 may be worn or otherwise attached on or underneath clothing of the user-patient. Similarly, thedelivery device 12 may be supported by any suitable manner, such as, but not limited to, on a belt, in a pocket, and the like. Representative examples ofsuch delivery devices 12, and delivery devices in general, may include, but is not limited to, the MiniMed Paradigm 522 Insulin Pump, MiniMed Paradigm 722 Insulin Pump, MiniMed Paradigm 515 Insulin Pump, MiniMed Paradigm 715 Insulin Pump, MiniMed Paradigm 512R Insulin Pump, MiniMed Paradigm 712R Insulin Pump, MiniMed 508 Insulin Pump, MiniMed 508R Insulin Pump, and any other derivatives thereof. - The
reservoir system 40 may be configured for containing or holding fluidic media, such as, but not limited to insulin. In various embodiments, thereservoir system 40 may include a hollow interior volume for receiving fluidic media, such as, but not limited to, a cylinder-shaped volume, a tubular-shaped volume, or the like. In some embodiments, thereservoir system 40 may be provided as a cartridge or canister for containing fluidic media. In various embodiments, thereservoir system 40 can be refilled with fluidic media. In further embodiments, thereservoir system 40 is pre-filled with fluidic media. - The
reservoir system 40 may be supported by thedisposable housing 20 in any suitable manner. For example, thedisposable housing 20 may be provided with projections or struts (not shown), or a trough feature (not shown), for holding thereservoir system 40. In some embodiments, thereservoir system 40 may be supported by thedisposable housing 20 in a manner that allows thereservoir system 40 to be removed from thedisposable housing 20 and replaced with another reservoir. Alternatively, or in addition, thereservoir system 40 may be secured to thedisposable housing 20 by a suitable adhesive, a strap, or other coupling structure. - In various embodiments, the
reservoir system 40 may include at least oneport 41 for allowing fluidic media to flow into and/or flow out of the interior volume of thereservoir system 40. In some embodiments, theinfusion path 50 may include aconnector 56, atube 54, and aneedle apparatus 52. Theconnector 56 of theinfusion path 50 may be connectable to theport 41 of thereservoir system 40. In various embodiments, thedisposable housing 20 may be configured with an opening near theport 41 of thereservoir system 40 for allowing theconnector 56 of theinfusion path 50 to be selectively connected to and disconnected from theport 41 of thereservoir system 40. - In various embodiments, the
port 41 of thereservoir system 40 may be covered with or supports a septum (not shown inFIG. 2 ), such as a self-sealing septum, or the like. The septum may be configured to prevent fluidic media from flowing out of thereservoir system 40 through theport 41 when the septum is not pierced. In addition, in various embodiments, theconnector 56 of theinfusion path 50 may include a needle for piercing the septum covering theport 41 of thereservoir system 40 to allow fluidic media to flow out of the interior volume of thereservoir system 40. - Examples of needle/septum connectors can be found in U.S. patent application Ser. No. 10/328,393, filed Dec. 22, 2003, entitled “Reservoir Connector,” which is incorporated herein by reference in its entirety. In other alternatives, non-septum connectors such as Luer locks, or the like may be used. In various embodiments, the
needle apparatus 52 of theinfusion path 50 may include a needle that is able to puncture the skin of the user-patient. In addition, in various embodiments, thetube 54 connects theconnector 56 with theneedle apparatus 52 and may be hollow, such that theinfusion path 50 is able to provide a path to allow for the delivery of fluidic media from thereservoir system 40 to the body of a user-patient. - The
durable housing 30 of thedelivery device 12 in accordance with various embodiments of the present invention includes a housing shell configured to mate with and secure to thedisposable housing 20. Thedurable housing 30 and thedisposable housing 20 may be provided with correspondingly shaped grooves, notches, tabs, or other suitable features that allow the two parts to connect together easily, by manually pressing the two housings together, by twist or threaded connection, or other suitable manner of connecting the parts that is well known in the mechanical arts. - In various embodiments, the
durable housing 30 and thedisposable housing 20 may be connected to each other using a twist action. Thedurable housing 30 and thedisposable housing 20 may be configured to be separable from each other when a sufficient force is applied to disconnect the two housings from each other. For example, in some embodiments thedisposable housing 20 and thedurable housing 30 may be snapped together by friction fitting. In various embodiments, a suitable seal, such as an o-ring seal, may be placed along a peripheral edge of thedurable housing 30 and/or thedisposable housing 20 to provide a seal against water entering between thedurable housing 30 and thedisposable housing 20. - The
durable housing 30 of thedelivery device 12 may support a drive device (not shown inFIG. 2 ), including a motor and a drive device linkage portion, for applying a force to fluidic media within thereservoir system 40 to force fluidic media out of thereservoir system 40 and into an infusion path, such as theinfusion path 50, for delivery to a user-patient. For example, in some embodiments, an electrically driven motor may be mounted within thedurable housing 30 with appropriate linkage for operatively coupling the motor to a plunger arm (not shown inFIG. 2 ) connected to a plunger head (not shown inFIG. 2 ) that is within thereservoir system 40 and to drive the plunger head in a direction to force fluidic media out of theport 41 of thereservoir system 40 and to the user-patient. - Also, in some embodiments, the motor may be controllable to reverse direction to move the plunger arm and the plunger head to cause fluid to be drawn into the
reservoir system 40 from a patient. The motor may be arranged within thedurable housing 30 and thereservoir system 40 may be correspondingly arranged on thedisposable housing 20, such that the operable engagement of the motor with the plunger head, through the appropriate linkage, occurs automatically upon the user-patient connecting thedurable housing 30 with thedisposable housing 20 of thedelivery device 12. Further examples of linkage and control structures may be found in U.S. patent application Ser. No. 09/813,660, filed Mar. 21, 2001, entitled “Control Tabs for Infusion Devices and Methods of Using the Same,” which is incorporated herein by reference in its entirety. - In various embodiments, the
durable housing 30 and thedisposable housing 20 may be made of suitably rigid materials that maintain their shape, yet provide sufficient flexibility and resilience to effectively connect together and disconnect, as described above. The material of thedisposable housing 20 may be selected for suitable compatibility with skin. For example, thedisposable housing 20 and thedurable housing 30 of thedelivery device 12 may be made of any suitable plastic, metal, composite material, or the like. Thedisposable housing 20 may be made of the same type of material or a different material relative to thedurable housing 30. In some embodiments, thedisposable housing 20 and thedurable housing 30 may be manufactured by injection molding or other molding processes, machining processes, or combinations thereof - For example, the
disposable housing 20 may be made of a relatively flexible material, such as a flexible silicone, plastic, rubber, synthetic rubber, or the like. By forming thedisposable housing 20 of a material capable of flexing with the skin of a user-patient, a greater level of user-patient comfort may be achieved when thedisposable housing 20 is secured to the skin of the user-patient. In addition, a flexibledisposable housing 20 may result in an increase in site options on the body of the user-patient at which thedisposable housing 20 may be secured. - In the embodiment illustrated in
FIG. 2 , thedelivery device 12 is connected to thesensing device 14 through aconnection element 17 of thesensing device 14. Thesensing device 14 may include asensor 15 that includes any suitable biological or environmental sensing device, depending upon a nature of a treatment to be administered by thedelivery device 12. For example, in the context of delivering insulin to a diabetes patient, thesensor 15 may include a blood glucose sensor, or the like. - In some embodiments, the
sensor 15 may include a continuous glucose sensor. The continuous glucose sensor may be implantable within the body of the user-patient. In other embodiments, the continuous glucose sensor may be located externally, for example on the skin of the user-patient, or attached to clothing of the user-patient. In such embodiments, fluid may be drawn continually from the user-patient and sensed by the continuous glucose sensor. In various embodiments, the continuous glucose sensor may be configured to sense and/or communicate with theCCD 16 continuously. In other embodiments, the continuous glucose sensor may be configured to sense and/or communicate with theCCD 16 intermittently, for example sense glucose levels and transmit information every few minutes. In various embodiments, the continuous glucose sensor may utilize glucose oxidase. - The
sensor 15 may be an external sensor that secures to the skin of a user-patient or, in other embodiments, may be an implantable sensor that is located in an implant site within the body of the user-patient. In further alternatives, the sensor may be included with as a part or along side the infusion cannula and/or needle, such as for example as shown in U.S. patent application Ser. No. 11/149,119, filed Jun. 8, 2005, entitled “Dual Insertion Set,” which is incorporated herein by reference in its entirety. In the illustrated example ofFIG. 2 , thesensor 15 is an external sensor having a disposable needle pad that includes a needle for piercing the skin of the user-patient and enzymes and/or electronics reactive to a biological condition, such as blood glucose level or the like, of the user-patient. In this manner, thedelivery device 12 may be provided with sensor data from thesensor 15 secured to the user-patient at a site remote from the location at which thedelivery device 12 is secured to the user-patient. - While the embodiment shown in
FIG. 2 may include asensor 15 connected by theconnection element 17 for providing sensor data to sensor electronics (not shown inFIG. 2 ) located within thedurable housing 30 of thedelivery device 12, other embodiments may employ asensor 15 located within thedelivery device 12. Yet other embodiments may employ asensor 15 having a transmitter for communicating sensor data by a wireless communication link with receiver electronics (not shown inFIG. 2 ) located within thedurable housing 30 of thedelivery device 12. In various embodiments, a wireless connection between thesensor 15 and the receiver electronics within thedurable housing 30 of thedelivery device 12 may include a radio frequency (RF) connection, an optical connection, or another suitable wireless communication link. Further embodiments need not employ thesensing device 14 and, instead, may provide fluidic media delivery functions without the use of sensor data. - As described above, by separating disposable elements of the
delivery device 12 from durable elements, the disposable elements may be arranged on thedisposable housing 20, while durable elements may be arranged within a separabledurable housing 30. In this regard, after a prescribed number of uses of thedelivery device 12, thedisposable housing 20 may be separated from thedurable housing 30, so that thedisposable housing 20 may be disposed of in a proper manner. Thedurable housing 30 may then be mated with a new (un-used)disposable housing 20 for further delivery operation with a user-patient. -
FIG. 3 illustrates an example of thedelivery device 12 in accordance with another embodiment of the present invention. Thedelivery device 12 of the embodiment ofFIG. 3 is similar to thedelivery device 12 of the embodiment ofFIG. 2 . While thedelivery device 12 in the embodiment illustrated inFIG. 2 provides for thedurable housing 30 to cover thereservoir system 40, thedelivery device 12 in the embodiment ofFIG. 3 provides for thedurable housing 30 to secure to thedisposable housing 20 without covering thereservoir system 40. Thedelivery device 12 of the embodiment illustrated inFIG. 3 includes thedisposable housing 20, and thedisposable housing 20 in accordance with the embodiment illustrated inFIG. 3 includes abase 21 and areservoir retaining portion 24. In one embodiment, thebase 21 andreservoir retaining portion 24 may be formed as a single, unitary structure. - The
base 21 of thedisposable housing 20 may be configured to be securable to a body of a user-patient. The reservoir-retainingportion 24 of thedisposable housing 20 is configured to house thereservoir system 40. The reservoir-retainingportion 24 of thedisposable housing 20 may be configured to have an opening to allow for theport 41 of thereservoir system 40 to be accessed from outside of the reservoir-retainingportion 24 while thereservoir system 40 is housed in the reservoir-retainingportion 24. Thedurable housing 30 may be configured to be attachable to and detachable from thebase 21 of thedisposable housing 20. Thedelivery device 12 in the embodiment illustrated inFIG. 3 includes aplunger arm 60 that is connected to or that is connectable to a plunger head (not shown inFIG. 3 ) within thereservoir system 40. -
FIG. 4 illustrates another view of thedelivery device 12 of the embodiment ofFIG. 3 . Thedelivery device 12 of the embodiment illustrated inFIG. 4 includes thedisposable housing 20, thedurable housing 30, and theinfusion path 50. Thedisposable housing 20 in the embodiment ofFIG. 4 includes thebase 21, the reservoir-retainingportion 24, and apeelable cover layer 25. Thepeelable cover layer 25 may cover an adhesive material on thebottom surface 22 of thebase 21. Thepeelable cover layer 25 may be configured to be peelable by a user-patient to expose the adhesive material on thebottom surface 22 of thebase 21. In some embodiments, there may be multiple adhesive layers on thebottom surface 22 of the base 21 that are separated by peelable layers. - The
infusion path 50 in accordance with the embodiment of the present invention illustrated inFIG. 4 includes theneedle 58 rather than theconnector 56, thetube 54, and theneedle apparatus 52 as shown in the embodiment ofFIG. 2 . Thebase 21 of thedisposable housing 20 may be provided with an opening or pierceable wall in alignment with a tip of theneedle 58, to allow theneedle 58 to pass through thebase 21 and into the skin of a user-patient under thebase 21, when extended. In this manner, theneedle 58 may be used to pierce the skin of the user-patient and deliver fluidic media to the user-patient. - Alternatively, the
needle 58 may be extended through a hollow cannula (not shown inFIG. 4 ), such that upon piercing the skin of the user-patient with theneedle 58, an end of the hollow cannula is guided through the skin of the user-patient by theneedle 58. Thereafter, theneedle 58 may be removed, leaving the hollow cannula in place, with one end of the cannula located within the body of the user-patient and the other end of the cannula in fluid flow connection with fluidic media within thereservoir system 40, to convey pumped infusion media from thereservoir system 40 to the body of the user-patient. -
FIG. 5A illustrates adurable portion 8 of the delivery device 12 (refer toFIG. 3 ) in accordance with an embodiment of the present invention.FIG. 5B illustrates a section view of thedurable portion 8 in accordance with an embodiment of the present invention.FIG. 5C illustrates another section view of thedurable portion 8 in accordance with an embodiment of the present invention. With reference toFIGS. 5A , 5B, and 5C, in various embodiments, thedurable portion 8 may include thedurable housing 30, and adrive device 80. Thedrive device 80 may include amotor 84 and a drivedevice linkage portion 82. - In various embodiments, the
durable housing 30 may include an interior volume for housing themotor 84, the drivedevice linkage portion 82, other electronic circuitry, and a power source (not shown inFIGS. 5A , 5B, and 5C). In addition, in various embodiments, thedurable housing 30 may be configured with anopening 32 for receiving a plunger arm 60 (refer toFIG. 3 ). In addition, in various embodiments, thedurable housing 30 may include one ormore connection members 34, such as tabs, insertion holes, or the like, for connecting with thebase 21 of the disposable housing 20 (refer toFIG. 3 ). -
FIG. 6A illustrates adisposable portion 9 of the delivery device 12 (refer toFIG. 3 ) in accordance with an embodiment of the present invention.FIG. 6B illustrates a section view of thedisposable portion 9 in accordance with an embodiment of the present invention.FIG. 6C illustrates another section view of thedisposable portion 9 in accordance with an embodiment of the present invention. With reference toFIGS. 6A , 6B, and 6C, in various embodiments, thedisposable portion 9 includes thedisposable housing 20, thereservoir system 40, theplunger arm 60, and aplunger head 70. In some embodiments, thedisposable housing 20 may include thebase 21 and the reservoir-retainingportion 24. In various embodiments, thebase 21 may include atop surface 23 having one ormore connection members 26, such as tabs, grooves, or the like, for allowing connections with the one ormore connection members 34 of embodiments of the durable housing 30 (refer toFIG. 5B ). - In various embodiments, the
reservoir system 40 may be housed within thereservoir retaining portion 24 of thedisposable housing 20, and thereservoir system 40 may be configured to hold fluidic media. In addition, in various embodiments, theplunger head 70 may be disposed at least partially within thereservoir system 40 and may be moveable within thereservoir system 40 to allow fluidic media to fill into thereservoir system 40 and to force fluidic media out of thereservoir system 40. In some embodiments, theplunger arm 60 may be connected to or is connectable to theplunger head 70. - Also, in some embodiments, a portion of the
plunger arm 60 may extend to outside of the reservoir-retainingportion 24 of thedisposable housing 20. In various embodiments, theplunger arm 60 may have a mating portion for mating with the drivedevice linkage portion 82 of the drive device 80 (refer toFIG. 5C ). With reference toFIGS. 5C and 6C , in some embodiments, thedurable housing 30 may be snap fitted onto thedisposable housing 20, whereupon the drivedevice linkage portion 82 automatically engages the mating portion of theplunger arm 60. - When the
durable housing 30 and thedisposable housing 20 are fitted together with the drivedevice linkage portion 82 engaging or mating with theplunger arm 60, themotor 84 may be controlled to drive the drivedevice linkage portion 82 and, thus, move theplunger arm 60 to cause theplunger head 70 to move within thereservoir system 40. When the interior volume of thereservoir system 40 is filled with fluidic media and an infusion path is provided from thereservoir system 40 to the body of a user-patient, theplunger head 70 may be moved within thereservoir system 40 to force fluidic media from thereservoir system 40 and into the infusion path, so as to deliver fluidic media to the body of the user-patient. - In various embodiments, once the
reservoir system 40 has been sufficiently emptied or otherwise requires replacement, the user-patient may simply remove thedurable housing 30 from thedisposable housing 20, and replace thedisposable portion 9, including thereservoir system 40, with a new disposable portion having a new reservoir. Thedurable housing 30 may be connected to the new disposable housing of the new disposable portion, and the delivery device including the new disposable portion may be secured to the skin of a user-patient, or otherwise attached to the user-patient. - In various other embodiments, rather than replacing the entire
disposable portion 9 every time thereservoir system 40 is emptied, thereservoir system 40 may be refilled with fluidic media. In some embodiments, thereservoir system 40 may be refilled while remaining within the reservoir retaining portion 24 (refer toFIG. 6B ) of thedisposable housing 20. In addition, in various embodiments, thereservoir system 40 may be replaced with a new reservoir (not shown), while thedisposable housing 20 may be re-used with the new reservoir. In such embodiments, the new reservoir may be inserted into thedisposable portion 9. - With reference to
FIGS. 3 , 5A, 6B, and 6C, in various embodiments, thedelivery device 12 may include reservoir status circuitry (not shown), and thereservoir system 40 may include reservoir circuitry (not shown). In various embodiments, the reservoir circuitry stores information such as, but not limited to, at least one of (i) an identification string identifying thereservoir system 40; (ii) a manufacturer of thereservoir system 40; (iii) contents of thereservoir system 40; and (iv) an amount of contents in thereservoir system 40. In some embodiments, thedelivery device 12 may include the reservoir status circuitry (not shown), and the reservoir status circuitry may be configured to read data from the reservoir circuitry (not shown) when thereservoir system 40 is inserted into thedisposable portion 9. - In various embodiments, the reservoir status circuitry (not shown) may be further configured to store data to the reservoir circuitry after at least some of the contents of the
reservoir system 40 have been transferred out of thereservoir system 40 to update information in the reservoir circuitry (not shown) related to an amount of contents still remaining in thereservoir system 40. In some embodiments, the reservoir status circuitry (not shown) may be configured to store data to the reservoir circuitry (not shown) to update information in the reservoir circuitry (not shown) related to an amount of contents remaining in thereservoir system 40 when thereservoir system 40 is inserted into thedisposable portion 9. In some embodiments, thedelivery device 12 may include the reservoir status circuitry (not shown) and thereservoir system 40 may include the reservoir circuitry (not shown), and the reservoir status circuitry (not shown) may selectively inhibit use of thedelivery device 12 or may selectively provide a warning signal based on information read by the reservoir status circuitry (not shown) from the reservoir circuitry (not shown). - In addition, embodiments may be configured to establish a contiguous fluid flow passage for fluid transfer between a reservoir and the user-patient when the hollow needle or cannula is inserted into the user-patient. Needle-inserting devices according to embodiments of the present invention may be used with, connectable to and disconnectable from, or incorporated in a portion of an infusion medium delivery system. For example, a needle-inserting device may be connectable to a base structure of a pump-type delivery device for insertion of a needle, after which the needle-inserting device may be removed from the base structure, whereupon a further housing portion of the delivery device (containing components such as, but not limited to, a reservoir and pump or drive device) may be coupled to the base structure for operation.
- Alternatively, the needle-inserting device may be incorporated into the further housing portion that contains other components as described above. In yet other embodiments, the needle-inserting device may be connectable to (and releasable from) or incorporated within an injection site module or other housing that connects, for example, by flexible tubing, to other components of a medical device (such as, but not limited to an infusion medium delivery device). In yet other embodiments, needle inserter devices may be configured for use with systems other than infusion medium delivery systems, such as, but not limited to sensor and monitor systems, or the like.
- The structures and methods described with respect to
FIGS. 7-25 may be employed in any suitable device or system in which two members that, at some period of time, are not connected in fluid flow communication, are to be connected together in a manner that allows fluid to flow from one member to the other. In some embodiments, the structure and method is described with respect to a first member, which is in fluid flow with a fluid reservoir for containing an infusion medium, that may be connectable to a second member including an injection site structure in which a hollow needle or cannula is or may be inserted into a user-patient, for conveying fluid media to the user-patient. However, a connection structure according to embodiments of the present invention may be employed to connect any two (or more) members together for fluid flow communication with each other. - In
FIGS. 7-12 , an example of astructure 100 and method for connecting two members in fluid flow communication is described with reference to afirst member 102 and asecond member 103. Thefirst member 102 may include ahousing 104 on abase 106. Thehousing 104 may be formed integral with the base 106 or may be formed as a separate structure connected to the base 106 in a fixed relation to thebase 106. Thehousing 104 and the base 106 each may be made of any suitably rigid material, including, but not limited to plastic, metal, ceramic, composite material, or the like. - The
housing 104 may include aninjection site section 105 containing an injection site structure in which a hollow needle or cannula may be inserted into a user-patient for conveying fluidic media to or from the user-patient. Thehousing 104 may be made of a material of suitable strength and durability such as, but not limited to, plastic, metal, glass, or the like. In other embodiments, instead of or in addition to an injection site, thehousing 104 may contain, be part of, or be operatively connected to any other suitable structure for conveying, containing, and/or processing fluidic media. - The
second member 103 may also include ahousing 108. In some embodiments, thehousing 108 may include areservoir 107 for containing fluidic media. Thereservoir 107 may be configured and/or made of materials as previously described with respect to reservoir system 40 (e.g.,FIGS. 1-6C ). Thesecond member 103 may be held within or otherwise be covered by an outer housing 109 configured to attach to thebase 106. The outer housing 109 may be configured to connect to thebase 106 of thefirst member 102 by any suitable connection structure. In other embodiments, thesecond member 103 and/or thehousing 108 is a fluid conduit that may be in fluid flow with thereservoir 107 or the like, for example when coupled to thereservoir 107. - In particular embodiments, at least one of the outer housing 109 and the base 106 may include one or more flexible pawls, protrusions, indentations, or the like for engaging and/or receiving one or more corresponding pawls, protrusions, indentations, or the like on the other of the
base 106 and the outer housing 109 to provide a suitable connection structure. Alternatively or in addition, the connection structure may include adhesive material or other suitable connectors. - In other embodiments, the
housing 108 may be or be connected to a sensor housing (not shown) containing sensor components. In yet other embodiments, thehousing 108 may contain, be part of, or be operatively connected to any other suitable structure for conveying, containing, and/or processing fluidic media. Thehousing 108 may be made of any suitably rigid material, including, but not limited to, plastic, metal, ceramic, composite material, or the like. - The
housing 104 may have or be connected to areceptacle structure 110. Thereceptacle structure 110 may have anopening 112 leading into a chamber 114 within thereceptacle structure 110. In some embodiments, thereceptacle structure 110 may be part of thehousing 104 adjacent a section of thehousing 104 containing theinjection site section 105. In other embodiments, thereceptacle structure 110 may include a further housing connected to thehousing 104. - The
receptacle structure 110 may include afirst septum 116 located within the chamber 114 and may be moveable within the chamber 114 toward and away from theopening 112. Thereceptacle structure 110 may also include abias mechanism 118, which may apply a bias force on thefirst septum 116 in a direction toward theopening 112. Thebias mechanism 118 may be arranged for forcing thefirst septum 116 against theopening 112. One or more annular protrusions or one or more appropriately shaped or positionedprotrusions 120 adjacent theopening 112 may be provided to inhibit thefirst septum 116 from being forced out of the chamber 114 through theopening 112 by the force of thebias mechanism 118. - The
first septum 116 may have a front surface 116 a that is at least partially exposed through theopening 112 when thefirst septum 116 is urged against theopening 112 by thebias mechanism 118. Thefirst septum 116 may have aback surface 116 b facing toward an interior of the chamber 114. Thefirst septum 116 may be made of any suitable material that may be pierceable by a needle, such as, but not limited to, a natural or synthetic rubber material, silicon, or the like. In some embodiments, thefirst septum 116 may be made of a self-sealing material capable of sealing itself after a needle has pierced thefirst septum 116 and was subsequently withdrawn from thefirst septum 116. - In some embodiments, the
bias mechanism 118 may be a coil spring located within the chamber 114 on an opposite side of thefirst septum 116 with respect to the front surface 116 a. In other embodiments, thebias mechanism 118 may be provided in any suitable manner for biasing thefirst septum 116 toward theopening 112. These may include, but are not limited to, other types of springs, pressurized fluid within the chamber 114, a collapsible skirt structure extending from thefirst septum 116 with a natural or built-in spring force, chemical, substance that expands upon contact with another chemical or substance, or upon application of energy from an energy source such as a heat, laser, or other radiation source, or the like. For example, in some embodiments, thefirst septum 116 may have a flexible accordion-like configuration to allow expansion and contraction of the skirt structure. - A
needle 124 may be supported within the chamber 114. Theneedle 124 may be hollow and may have asharp end 124 a directed toward theback surface 116 b of thefirst septum 116. In some embodiments, theneedle 124 may be supported within thebias mechanism 118 such that a longitudinal axial dimension of theneedle 124 extends generally parallel to a longitudinal axial dimension of thebias mechanism 118. - The
needle 124 may be supported by a supporting structure located within thereceptacle structure 110. In some embodiments, the supporting structure may be a wall integral with thereceptacle structure 110. The supporting structure may be located, for example, on an opposite end of the chamber 114 relative to the end of the chamber 114 at which theopening 112 is located. In other embodiments, the supporting structure may be any suitable structure that is generally fixed relative to thereceptacle structure 110 and is able to support theneedle 124 in a generally fixed relation to thereceptacle structure 110. - The
needle 124 may be made of any suitably rigid material, including, but not limited to metal, plastic, ceramic, or the like, and may have a hollow channel extending in a lengthwise dimension of theneedle 124. The hollow channel in theneedle 124 may be open on thesharp end 124 a of theneedle 124 and may be open at anotherlocation 124 b along the lengthwise dimension of theneedle 124, such as, but not limited to, the needle end opposite thesharp end 124 a. The hollow channel in theneedle 124 may provide a fluid flow path between thesharp end 124 a of theneedle 124 and theopening 124 b of theneedle 124. In some embodiments, theopening 124 b of theneedle 124 may be connected in fluid flow communication with a manifold 128 in theinjection site section 105. - The
housing 108 of thesecond member 103 may include aconnection portion 130 having a hollowinterior chamber 132 and anopening 134 into theinterior chamber 132. Asecond septum 136 may be supported by thehousing 108 to seal theopening 134. Thesecond septum 136 may be supported in a fixed relation to thehousing 108, for example, within thehousing 108 at one end of theinterior chamber 132. - The
connection portion 130 of thehousing 108 may have a suitable shape and size to fit at least partially within theopening 112 of thereceptacle structure 110 in thefirst member 102 when thefirst member 102 and thesecond member 103 are connected together. In the drawings ofFIGS. 7 and 8 , thefirst member 102 and thesecond member 103 are shown in a separated, disconnected relation, wherein theconnection portion 130 of thehousing 108 is outside of theopening 112 of thereceptacle structure 110. By moving thefirst member 102 and thesecond member 103 together to insert theconnection portion 130 into theopening 112 of thehousing 108 an end surface of theconnection portion 130 may be urged against thefirst septum 116. This may cause the moveablefirst septum 116 to move relative to thehousing 108 against the force of thebias mechanism 118 toward the interior of the chamber 114. As thefirst septum 116 is moved toward the interior of thehousing 108, thesharp end 124 a of theneedle 124 may pierce thefirst septum 116. Continued relative movement of thefirst member 102 and thesecond member 103 together may cause thesharp end 124 a of theneedle 124 to pass through thefirst septum 116 in thefirst member 102, then pierce, and pass through thesecond septum 136 in thesecond member 103. - When the
first member 102 and thesecond member 103 are brought together (e.g.,FIG. 9 ), at least a portion of theconnection portion 130 may extend inside of thereceptacle structure 110. With reference toFIGS. 8 and 9 , theneedle 124 may pierce thefirst septum 116 and thesecond septum 136 to form a fluid flow path between theinterior chamber 132 of theconnection portion 130 and the manifold 128 or other structure at theopening 124 b of theneedle 124. Thereceptacle structure 110 and theconnection portion 130 may be provided with mating connectors that provide, for example, a snap or friction connection upon thefirst member 102 and thesecond member 103 being brought together as shown inFIG. 9 . In some embodiments, the mating connectors may include a protrusion (not shown) on one or the other of thereceptacle structure 110 and theconnection portion 130. The other of thereceptacle structure 110 and theconnection portion 130 may include a groove or indentation (not shown) arranged to engage each other in a snap-fitting manner upon theconnection portion 130 being extended into the receptacle structure 110 a suitable distance. - As mentioned above, in some embodiments, the
opening 124 b of theneedle 124 may be connected in fluid flow communication with the manifold 128 in theinjection site section 105. Theinjection site section 105 may include achannel 140 extending through thehousing 104 and thebase 106. Thechannel 140 may have anopen end 140 a on a bottom surface (relative to the orientation shown inFIG. 8 ) of thebase 106. Thechannel 140 may have anotheropen end 140 b at an upper surface (relative to the orientation shown inFIG. 8 ) of theinjection site section 105 of thehousing 104. - The manifold 128 may be located along a length of the
channel 140 and may be in fluid flow communication with thechannel 140. Accordingly, theneedle 124 may be arranged in fluid flow communication with the interior of thechannel 140 through themanifold 128. Thechannel 140 may include achannel section 142 having a larger radial dimension relative to a remaining portion of thechannel 140 and may have a suitable shape and size to receive a needle and/or cannula, as will be described later. The manifold 128 may be made of a material of suitable strength and durability such as, but not limited to, plastic, metal, glass, or the like. - A needle-inserting
device 144 may be located adjacent theopen end 140 b of thechannel 140 and arranged to selectively extend a needle and/or cannula into theopen end 140 b of thechannel 140 and at least partially through thechannel 140 as will be described. In various embodiments, the needle-insertingdevice 144 may be configured to be integral with or otherwise fixed to thesection 105 of thehousing 104 of thefirst member 102. In other embodiments, the needle-insertingdevice 144 may be a separate device from thehousing 104 and may be selectively engaged or connected to, for example in alignment with the channel 140 (e.g.,FIG. 8 ), and disengaged or disconnected from theinjection site section 105 of thehousing 104. - In embodiments in which the needle-inserting
device 144 is a separate structure that connects to and disconnects from theinjection site section 105, a suitable connection structure may be provided on the needle-insertingdevice 144 and/or theinjection site section 105 to provide a manually releasable connection between those components. For example, the connection structure may include, but is not limited to, a threaded extension on one or the other of the needle-insertingdevice 144 and theinjection site section 105 and a corresponding threaded receptacle on the other of theinjection site section 105 and the needle-insertingdevice 144 for receiving and mating with the threaded extension in threaded engagement. In other embodiments, other suitable connection structures may be employed, including, but not limited to, flexible pawls or extensions on one or the other of the needle-insertingdevice 144 and theinjection site section 105 and a corresponding aperture, stop surface, or the like on the other of the other of theinjection site section 105 and the needle-insertingdevice 144 or friction fitting engageable portions on each of thesection 105 and needle-insertingdevice 144. - In the drawing of
FIG. 8 , the needle-insertingdevice 144 is shown as connected to theinjection site section 105 with aneedle 146 and acannula 148 in a retracted state. With reference toFIGS. 7-16 , the needle-insertingdevice 144 may be operated to selectively move theneedle 146 and thecannula 148 from the retracted state (e.g.,FIG. 8 ) to an extended state (e.g.,FIG. 13 ) in which theneedle 146 and thecannula 148 extend through theopening 140 b of thechannel 140 and at least partially through thechannel 140 such that asharp end 146 a of theneedle 146 and at least a portion of the length of thecannula 148 extend out the opening 140 a of thechannel 140. - Various examples of suitable structures for needle-inserting devices are described in U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, entitled “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method,” which is assigned to the assignee of the present invention and is incorporated herein by reference in its entirety. Further examples of various needle-inserting devices are described in, but are not limited to, U.S. patent application Ser. No. 11/645,972, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,052, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,000, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method,”, all of which are herein incorporated by reference in its entirety. Other examples of suitable structures for needle-inserting devices are described herein.
- The
cannula 148 may have a hollowcentral channel 148 c extending along a longitudinal length of thecannula 148 and open at oneend 148 a that may be adjacent thesharp end 146 a of theneedle 146. Anend 148 b of thecannula 148 opposite theopen end 148 a may have ahead 150 having a larger radial dimension than ashaft portion 148 d of thecannula 148. Thecannula head 150 may have a suitable shape and size to fit into thechannel section 142 of thechannel 140 when theneedle 146 and thecannula 148 are moved to the extended state by the needle-insertingdevice 144. - In particular embodiments, the
cannula head 150 may include one or more protrusions and/or indentations for engaging one or more corresponding indentations and/or protrusions in thechannel section 142 of theinjection site section 105 to provide a friction fit, snap fit, or the like. Accordingly, thecannula 148 may be locked or retained within theinjection site section 105 upon theneedle 146 andcannula 148 being moved to the extended state by the needle-insertingdevice 144. In further embodiments, instead of or in addition to engaging protrusions and indentations, one or more other mechanical structures may be employed to provide a suitable retaining function for retaining thecannula 148 in place within theinjection site section 105, including, but not limited to, a friction fit structure, snap fit, or the like. - The
cannula 148 may have a connection channel 152 provided in fluid flow communication with the hollowcentral channel 148 c of thecannula 148. The connection channel 152 may be provided along the longitudinal length of thecannula 148 at a location at which the connection channel 152 aligns with the manifold 128 (i.e., in fluid flow communication with an interior of the manifold 128) when theneedle 146 and thecannula 148 have been moved to the extended state by the needle-insertingdevice 144. In this manner, upon thecannula 148 being moved to the extended state, the hollowcentral channel 148 c of thecannula 148 may be arranged in fluid flow communication with thereservoir 108 through the manifold 128 and the connection channel 152. - Thus, according to some embodiments, in operation, a
first member 102, which may include, for example, ahousing 104 having areceptacle 110 and aninjection site section 105, may be coupled together with asecond member 103, which may include, for example, ahousing 108 having areservoir 107. Thefirst member 102 may be coupled or otherwise operatively connected, by inserting aconnection portion 130 of thesecond member 103 into areceptacle 110 of thefirst member 102. Upon coupling thefirst member 102 and thesecond member 103, fluid flow communication may be provided between thesecond member 103 and theinjection site section 105 in thefirst member 102. - In various embodiments, the needle-inserting
device 144 may be coupled to theinjection site section 105 of thehousing 104 of thefirst member 102 or may be provided as part of a single, unitary structure (i.e., integral) with theinjection site section 105 of thehousing 104. In some embodiments, thebase 106 of thefirst member 102 may be secured to skin of a user-patient at a suitable injection location with, for example, but not limited to, adhesive material as described in U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, entitled “Infusion Medium Delivery system, Device And Method With Needle Inserter And Needle Inserter Device And Method,” and/or as described herein. Alternatively or in addition, thebase 106 may be secured to the user-patient by one or more other suitable structures, including, but not limited to, straps, or the like. - Once the
base 106 is suitably secured to the skin of the user-patient at a suitable injection location, the insertingdevice 144 may be actuated to move theneedle 146 and thecannula 148 from a retracted state (e.g.,FIG. 8 ) to an extended state. In the extended state, theneedle 146 and/or thecannula 148 may pierce the skin of the user-patient adjacent thebase 106. Thecannula 148 may be locked into its extended state by engagement of thecannula head 150 and thechannel section 142, as previously described. - With the
cannula 148 locked in the extended state, theneedle 146 may be retracted, for example, by automatic operation of the needle-insertingdevice 144 and/or by manual removal of the needle-insertingdevice 144 from theinjection site section 105. Once theneedle 146 is removed, thecannula 148 may be held in place by theinjection site section 105 with a portion of thecannula 148 extending into the user-patient. As such, thecannula 148 may be connected in fluid-flow communication with theneedle 124. Accordingly, by connecting thefirst member 102 and thesecond member 103, as described above, then a fluid-flow connection may be provided from thereservoir 107 to thecannula 148 through theneedle 124 and themanifold 128. - A connection sequence (e.g., the sequence of connecting the needle-inserting
device 144 to theinjection site section 105 of thehousing 104, connecting thereceptacle 110 of thehousing 104 to theconnection portion 130 of thehousing 108 having thereservoir 107, and connecting thebase 106 of thefirst member 102 to the skin of the user-patient) for connecting various components may be different for different embodiments. In some embodiments, the user-patient may be provided with afirst member 102 having a base 106, ahousing 104, and aninjection site section 105 in a pre-connected state with the needle-insertingdevice 144. In this manner, a user-patient need not have to connect the needle-insertingdevice 144 to thehousing 104 as those parts are supplied to the user in a pre-connected state, for example, from a manufacturing or assembly facility. In such embodiments, thebase 106 of thefirst member 102 may be secured to skin of the user-patient at a suitable injection location. After securing the base 106 to the skin of the user-patient, the needle-insertingdevice 144 may be activated to cause theneedle 146 and thecannula 148 to be moved to the extended state and pierce the skin of the user-patient. - After activation of the needle-inserting
device 144, the needle-insertingdevice 144 may be removed from theinjection site section 105, thus leaving thecannula 148 in place within theinjection site section 105 and partially extended into the user-patient. With thebase 106 of thefirst member 102 secured to the skin of the user-patient and thecannula 148 inserted at least partially into the user-patient and arranged in fluid-flow communication with theneedle 124, thesecond member 103 may be connected to thefirst member 102. In particular, theconnection portion 130 of thehousing 108 of thesecond member 103 may be inserted into thereceptacle 110 of thehousing 104 of thefirst member 102 to provide a fluid-flow connection between the interior of thehousing 108 and theneedle 124 and, thus, thecannula 148. Accordingly, thehousing 108, which may include thereservoir 107, for example, may be coupled in fluid-flow communication with thecannula 148 that has been extended into the user-patient for delivering fluid from thereservoir 107 to the user-patient. In other embodiments, such a connection may be for conveying fluid from the user-patient to thereservoir 107. - While the connection sequence in some of the above embodiments involve securing the
base 106 of thefirst member 102 to the user-patient prior to connection of thesecond member 103 to thefirst member 102, in other embodiments, thesecond member 103 may be connected to thefirst member 102, as described above, prior to securing thebase 106 of thefirst member 102 onto the skin of the user-patient. In such embodiments, thefirst member 102 and thesecond member 103 may be connected together and, thereafter, may be secured to the user-patient, for example, by adhering one or both of thefirst member 102 and thesecond member 103 to the skin of the user-patient. In addition, while the connection sequence in the above embodiments involve activating the needle-insertingdevice 144 prior to the connection of thesecond member 103 to thefirst member 102, in other embodiments, thesecond member 103 may be connected to thefirst member 102, as described above, prior to activating the needle-insertingdevice 144. - In some embodiments, such as the embodiments shown in
FIGS. 7 and 8 , thereceptacle 110 may be in thefirst member 102 and theconnection portion 130 may be in thesecond member 103. In other embodiments, thereceptacle 110 may be in thesecond member 103, for example, in or associated with a housing for a reservoir and theconnection portion 130 may be in thefirst member 102, for example, in or associated with a housing containing an injection site structure. - In some embodiments, such as the embodiments shown in
FIGS. 7 and 8 , thereceptacle 110 may be arranged to allow theconnection portion 130 of thesecond member 103 to be inserted in a direction substantially parallel to a plane of an upper-facing (in the orientation ofFIG. 7 ) surface of thebase 106. For example, in the orientation ofFIG. 7 , the direction of insertion is shown as a horizontal direction of relative motion between thefirst member 102 and thesecond member 103. - Again referring to
FIGS. 7 and 8 , in other embodiments, thereceptacle 110 may be arranged in other suitable orientations, including, but not limited to, an orientation allowing an insertion direction (i.e., relative motion of thefirst member 102 and the second member 103) to be substantially perpendicular to the plane of the upper-facing surface of thebase 106. In yet other embodiments, thereceptacle 110 may be arranged to allow any other suitable insertion direction at a non-perpendicular angle transverse to the plane of the upper-facing surface of thebase 106. - An example arrangement shown in
FIGS. 13-16 provides an insertion direction (i.e., relative motion of thefirst member 102 and the second member 103) that may be substantially perpendicular to the plane of the upper-facing (in the orientation ofFIG. 8 ) surface of thebase 106. Components inFIGS. 13-16 are identified by reference numbers that are the same as reference numbers used inFIGS. 7-12 for components having similar structure and function. InFIGS. 13 and 14 , theinjection site section 105 in thehousing 104 is shown in a state after a needle-inserting device has been operated to move acannula 148 to the extended position. -
FIGS. 15 and 16 show thebase 106 of the first member 102 (of the embodiment ofFIGS. 13 and 14 ) with a needle-insertingdevice 144 attached to thehousing 104. The needle-insertingdevice 144 may include ahousing 160 adapted to be securable to the base 106 in any suitable manner, such as, but not limited to the manners of connecting a needle-insertingdevice 144 to theinjection site structure 105 discussed above with respect to the embodiment ofFIGS. 7-12 . Returning toFIGS. 15 and 16 , thehousing 160 may contain an internal chamber having a longitudinal dimension L and amoveable plunger 162 located within thehousing 160 and moveable along the longitudinal dimension L from a retracted position (shown in solid lines inFIG. 16 ) to an extended position (in which theplunger 162 is moved to a position E shown in broken lines inFIG. 16 ). - A
bias member 164, such as, but not limited to, a coil spring arranged within thehousing 160 may be configured to impart a bias force on theplunger 162 when theplunger 162 is in the refracted position to urge theplunger 162 toward the extended position E. A locking mechanism (not shown) may be provided such as, but not limited to, a manually moveable projection, lever, slider, or the like, connected to or extending through thehousing 160 and engages theplunger 162 or other structure holding theplunger 162 in a releasable manner to selectively hold theplunger 162 in its refracted state against the bias force of thebias member 164 and to allow a user-patient to selectively release theplunger 162 to move in the longitudinal direction L under the force of thebias member 164. - An
insert structure 166 may be arranged within thehousing 160 for movement in the longitudinal direction L by action of movement of theplunger 162. Theinsert structure 166 may include, for example, a cup-shapedbody 168. The cup-shapedbody 168 may be made of a material of suitable strength and durability such as, but not limited to, plastic, metal, glass, or the like. The cup-shapedbody 168 may hold afirst septum 116. Theseptum 116 may be made of a material such as silicone, rubber, plastic, a resealable membrane, or the like. - A
hollow cannula 148 may have oneopen end 148 a and a sharp tip arranged adjacent thefirst septum 116 or at least partially within thefirst septum 116. Thehollow cannula 148 may extend through the cup-shapedbody 168 and may have a secondopen end 148 b. Thehollow cannula 148 may be fixed to the cup-shapedbody 168 to move with movement of the cup-shapedbody 168. Aneedle 170 may be secured to theplunger 162 and may extend through thefirst septum 116 andcannula 148 when theplunger 162 is in the retracted position. - In operation, the user-patient (or medical practitioner) may secure the base 106 to skin of the user-patient, for example, as previously described. Once the
base 106 is secured to the skin of the user-patient, the user-patient (or medical practitioner) may activate the needle-insertingdevice 144 to cause theplunger 162 to move from the retracted position to the extended position E and, as a result of such movement, to cause theinsert structure 166 to be moved into an opening into the interior of thehousing 104. Upon movement of theinsert structure 166 into thehousing 104, theinsert structure 166 may connect to thehousing 104 by any suitable connection structure. - As discussed above, in particular embodiments, one or the other of the cup-shaped
body 168 of theinsert structure 166 and thehousing 104 may include one or more flexible pawls, protrusions, indentations, or the like, for engaging and receiving one or more corresponding pawls, protrusions, indentations, or the like, on the other of thehousing 104 and theinsert structure 166 to provide a suitable connection structure. Alternatively or in addition, the connection structure may include adhesive material or other suitable connectors. - In particular embodiments, the
housing 160 of the needle-insertingdevice 144 may automatically release from the base 106 upon movement of theplunger 162 and theinsert structure 166 from the retracted position to the extended position E. For example, thehousing 160 of the needle-insertingdevice 144 may be made of a material that has sufficient rigidity to operate as described herein, but also has a suitable flexibility (at least at the portion of thedevice 144 that connects to the housing 104) to bend away from and release from thehousing 104 upon movement of theinsert structure 166 to the extended position E. - In some embodiments, such as the embodiment shown in
FIG. 16 , aportion 172 of the internal surface of thehousing 160 may include a ramped, wedge-shaped, or angled (relative to an axial direction of thehousing 144,cannula 148, and needle 170) cross-sectional shape that engages an outer peripheral surface of theinsert structure 166 and/or theplunger 162 as theinsert structure 166 andplunger 162 are moved toward the extended position E. By engaging the angled, ramped, or wedge-shapedportion 172 of the internal surface of thehousing 160, theplunger 162 and/or theinsert structure 166 may cause the wall(s) of thehousing 160 to flex outward as theplunger 162 and/or insertstructure 166 are moved into the extended position. One or more slots, grooves, or the like 174 may be formed in thehousing 166 to enhance the ability of the wall(s) of thehousing 160 to flex outward. One ormore protrusions 176 and/or indentations may be provided on one or the other of the interior surface of thehousing 166 and the exterior surface of thehousing 104 for engaging one or more corresponding indentations 178 and/or protrusions in the other of thehousing 104 andhousing 166 when theplunger 162 and insertstructure 166 are in the retracted state shown inFIG. 16 . - The one or
more protrusions 176 and the one or more indentations 178, when engaged, may lock thehousing 160 of the needle-insertingdevice 144 to thehousing 104. The one ormore protrusions 176 and/or indentations 178 may disengage from each other when the wall(s) of thehousing 160 are flexed outward by the movement of theplunger 162 and theinsert structure 166 to the extended position E. As a result, thehousing 160 of the needle-insertingdevice 144 may be automatically disengaged and released from thehousing 104 upon movement of theplunger 162 and insertstructure 166 to the extended position E. - After movement of the
plunger 162 and insertstructure 166 from the refracted position (shown inFIG. 16 ) to the extended position E at which theinsert structure 166 may be locked into thehousing 104, while thehousing 160 of the needle-insertingdevice 144 is released from thehousing 104, the bias member 164 (or a second bias member (not shown)) may act on theneedle 170 to move theneedle 170 toward the retracted position and, thus, withdraw theneedle 170 from thecannula 148. For example, a return motion of the coil spring after moving from the retracted position to the extended position E may provide sufficient force to withdraw theneedle 170 from thecannula 148. - Once the
insert structure 166 has been locked into place within thehousing 104 and the needle-insertingdevice 144 has been removed from thehousing 104, thecannula 148 may be connected in fluid-flow communication with aconnection portion 130 of a second member such as, but not limited to, a reservoir, in a manner similar to the manner in which thefirst member 102 and thesecond member 103 are connectable in the embodiments ofFIGS. 7-12 . More specifically, thehousing 104 may form a receptacle (similar to thereceptacle 110 described above forFIGS. 7-12 ) and may contain thefirst septum 116. - Similar to the embodiment of
FIGS. 7-12 , theconnection portion 130 may also include asecond septum 136. In particular, theconnection portion 130 may be inserted into the receptacle formed by thehousing 104 to connect the interior of the reservoir in fluid-flow communication with thecannula 148. Thecannula 148 inFIG. 13 may include asharp end 148 a adjacent thefirst septum 116. As theconnection portion 130 is inserted into thehousing 104, the connection portion may push thefirst septum 116 against thesharp end 148 a of thecannula 148 to cause thesharp end 148 a of thecannula 148 to pierce thefirst septum 116. Further insertion motion of theconnection portion 130 into thehousing 104 may cause thesharp end 148 a of thecannula 148 to pierce thesecond septum 136 in theconnection portion 130 to form a flow path from or to theconnection portion 130 through thecannula 148. Other examples of fluid connections are disclosed in (but not limited to) U.S. patent application Ser. No. 12/553,308, filed Sep. 2, 2009; U.S. patent application Ser. No. 12/649172, filed Dec. 29, 2009; U.S. patent application Ser. No. 13/015028, filed Jan. 27, 2011; U.S. patent application Ser. No. 13/015051, filed Jan. 27, 2011, all of which are herein incorporated by reference in their entirety. - In various embodiments, a medical device may be configured to detect a connecting or otherwise positioning of one or more fluid conduits, such as but not limited to, the
cannula 148, theneedle 124, and/or the like in a predetermined manner. It should be noted that reference to a specific fluid conduit (e.g.,cannula 148,needle 124, etc.) is merely illustrative and that the conduit-positioning systems/methods may be implemented with any other fluid conduit. The medical device may be configured to detect a presence of fluidic media to be delivered into a patient's body that is in the one or more fluid conduits. The presence of fluidic media in a particular fluid conduit may indicate, for instance, that the fluid conduit (and/or fluid conduits connecting the particular fluid conduit and a source of the fluidic media) is properly connected and/or primed. - In some embodiments the fluidic media is insulin. In other embodiments, the fluidic media may be, but not limited to, HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, vitamins, hormones, and/or the like
- Most fluids designed for parenteral administration (and/or infusion) contain a preservative. The most commonly used preservatives are based either on a phenol system or a
benzyl alcohol system 34. Examples of these systems are disclosed in U.S. Pat. No. 6,461,329, which is herein incorporated by reference in its entirety. Accordingly, an approach to detecting whether a fluid conduit has been primed is to trigger a chemical reaction that is observable by an individual or detectable by the medial device when any of these preservatives are present in the fluid conduit. - In various embodiments, the
cannula 148 may include a chemical or the like for triggering the chemical reaction. For instance, the chemical may be applied to or otherwise provided to thecannula 148. In other cases, thecannula 148 may be impregnated with the chemical. In some embodiments, the chemical may include at least one of 4-amino-antipyrine and potassium ferricyanide (K3Fe(CN)6), as described for example in U.S. Pat. No. 6,461,329, which is herein incorporated by reference in its entirety. - In particular embodiments, the medical device is an infusion device with transparent parts or portions that allow an individual to see through the transparent parts and observe the chemical on or near the
cannula 148 or portion thereof. In various embodiments, the medical device may include other clear (optically transparent) materials, such as glass, creams, crystal, laminates, or the like for the individual to see through the medical device and observe the chemical on or near thecannula 148. In yet other embodiments, the medical device may include an opening or the like to allow the individual to observe the chemical on or near thecannula 148. - In other embodiments, the
cannula 148 may be configured to direct the fluidic media to an observation portion of the medical device. Accordingly, a chemical reaction at the observation portion can be observed. In other embodiments, portions of thecannula 148 may extend to a observation portion of the medical device. Accordingly, a chemical reaction at the observation portion can be observed. In such embodiments, portions of the medical device or the entire medical device may be opaque since the chemical reaction does not have to be observed through the medical device. - When fluidic media is present in the
cannula 148, the preservative in the parenteral fluid reacts with the 4-amino-antipyrine and potassium ferricyanide. The resulting product is a bright blue colored complex. Thus, the chemicals, seen through the medical device (or at another observable location), change from clear to bright blue, serving as a visual indicator to the individual that fluidic media is present in thecannula 148. The time required to detect presence of fluidic media may range from a few minutes (or less) to several hours due to the concentrations of the reactants, 4-amino-antipyrine and potassium ferricyanide, the concentration of the preservative in the fluidic media, the flow rate of the fluidic media, the rate at which the fluidic media spreads and comes in contact with the reactants, the method used to deposit the chemicals on or near thecannula 148, the temperature near thecannula 148, and/or the like. In alternative embodiments, the chemical may be some other color, such as white, cream, off white, or the like, or a contrasting color to make the color change noticeable. In other embodiments, the colored product is a different color, such as red, yellow, orange, pink, green, purple, or the like. - In alternative embodiments, an enzymatic system is used to amplify the chemical color change signal. An enzyme, such as horse radish peroxidase (HRP), is added to the chemical (4-aminoantipyrine and potassium ferricyanide. When fluidic media is present, water in the fluidic media dissolves the HRP. The HRP then acts as a catalyst to, in essence, create an enzymatic amplification of the signal. For instance, a deep blue colored complex is formed due to the phenol or benzyl alcohol preservatives in the fluidic media reacting with the 4-aminoantipyrine and the potassium ferricyanide. The advantage of the HRP system is that only very small amounts of the fluidic media need to be present to be detected. In such embodiments, the time required to detect presence of fluidic media may range from less than 20 seconds to over 4 hours depending on the concentration of HRP, the concentration of the reactants 4-aminoantipyrine and potassium ferricyanide, the flow rate of the fluidic media, the rate at which the fluidic media spreads and comes in contact with the reactants, the method used to deposit the chemicals on or near the
cannula 148, the temperature near thecannula 148, and/or the like. - In other embodiments, the 4-aminoantipyrine and potassium ferricyanide are encapsulated in micro-spheres. In particular embodiments, the micro-spheres dissolve in the presence of an ingredient contained in the fluidic media, such as water, alcohol, or the like, which then sets the reactants free to react with the preservative in the fluid as described above. Additional embodiments include HRP encapsulated in micro-spheres along with 4-aminoantipyrine and potassium ferricyanide.
- In other embodiments, where the fluidic media to be delivered into a patient's body includes a protein, such as an insulin formulation, other reactants may be located or near the
cannula 148 to produce a color change that signifies presence of fluidic media. In particular embodiments, ninhydrin, Coomassie Brilliant Blue, and/or the like reacts with the protein in the fluidic media resulting in a brightly colored product. While chemical reactions are effective at displaying a visual signal (a color change) when fluidic media is present, the individual must visually inspect around the medical device to see the visual signal. Thus, alternative methods of fluidic media detection utilize an audible or tactile notification of fluidic media presence in addition to, or instead of, a visual only signal. - In particular embodiments, optical or electrical detection methods provide a signal to electronics contained the medical device or remote from the medical device. When fluidic media is detected, the electronics activate an indicator, such as a vibrator, flashing lights or LEDs, an LCD message displaying the cause for the indicator, a small scintillating electric shock to the individual, a heating element, or the like. In other alternative embodiments, the indicator generates at least one notification signal such as by telemetry, radio frequency, optical, infra-red, ultrasonic, laser, telephone, pager, Wi-Fi, or the like. Infusion pump communication apparatuses and methods are disclosed in, but are not limited to, U.S. Pat. No. 6,936,029; U.S. Pat. No. 6,551,276; U.S. Pat. No. 6,554,798; U.S. Pat. No. 7,815,602, all of which are herein incorporated by reference in their entirety. In particular embodiments, an indicator notification is stored in a memory device such as an on-board memory chip, a computer memory, a PDA, computer disks, compact disks, a telephone message, a pager, or the like. In other embodiments, the indicator notifies a person other than the individual using the medical device (e.g., a doctor, a nurse, a parent, a spouse, a friend, a relative, a workmate, or the like.)
- Some embodiments employ an electro-optical detection system in combination with any of the chemical reactions that result in a colored chemical product like those previously described. In such embodiments, the medical device may include an optical receiver that receives light from near the
cannula 148. When chemical reactants produce a colored product, the optical receiver detects a change in the light indicating presence of fluidic media. The optical receiver provides an output signal to the electronics. - In particular embodiments, a miniature optical transmitter and receiver are located near the
cannula 148. The exterior surface of either the transmitter, or the receiver, or both, are coated with reactants that will produce a colored complex 40 in the presence of fluidic media. When fluidic media triggers the color change, the optical signal between the optical transmitter and optical receiver is altered. The optical signal may be carried to the electronics by a fiber optical cable (or the like), converted to an electrical signal and carried to the electronics by electrical wire, or the like. Accordingly, chemically activated color changes may be detected by the optical receiver through the fiber optic cable or the like. - In alternative embodiments, more than one fiber optic cable may be used to carry light from more than one location near the
cannula 148 to the optical receiver. In particular embodiments, the optical receiver and an optical transmitter are both located inside the medical device. A first fiber optic cable runs from the optical transmitter to a point near thecannula 148 and a second fiber optic cable runs from the optical receiver to a point near the cannula 147. The ends of the fiber optic cables near theinfusion site 30 may be positioned with respect to each other so that light emitted by the optical transmitter is detected by the optical receiver. A gap may exists between the ends of the fiber optic cables near thecannula 148. The reactants or carrier media containing the reactants may be placed in the gap between the ends of the fiber optic cables. When a fluidic media triggers a reaction producing a chemical color change, a change in the light signal is detected by the optical receiver. - In some embodiments, the optical receiver is located within the medical device and is positioned with respect to the
cannula 148 such that light coming from thecannula 148 is detected by the receiver to provide an indication that thecannula 148 is or is not properly positioned. - Other leak detection methods are based on electrical measurements. A medical device battery or the like may be an available source for the electrical power required to operate an electrically based detection apparatus. Electronics contained within the medical device may evaluate the signals from the electrically based detection apparatus.
- In various embodiments, a rosette, which is a pattern of one or more conducting elements, is provided in the medical device to substantially surround the
cannula 148. Examples of rosettes for detecting fluid presence are disclosed in, but are not limited to, U.S. Pat. No. 6,461,329, which is herein incorporated by reference in its entirety. - Conducting elements may be wires, sputtered carbon, plastics doped with conductive fillers, epoxies doped with conductive fillers, or the like. Particular embodiments employ an active electronic signal to detect changes in impedance across the rosette. For instance, a voltage is supplied across the rosette by running conductive leads from a medical device battery (or other power source) to different points on the rosette, such as opposite or adjacent endpoints. Then the impedance is measured across the rosette. When fluidic media interacts (e.g., comes in contact) with the rosette, the impedance changes and the electronics measure the change in impedance to detect presence of fluidic media.
- In some embodiments, as shown for example in
FIG. 17A , anuninterrupted rosette 246 is used such that when fluidic media is present near thecannula 148, portions of therosette 246 are shorted providing additional or shorter conductive paths across portions of the rosette, and the total impedance across therosette 246 is decreased. The reduction in impedance across therosette 246 is detected by the electronics which indicates presence of fluidic media. Many other uninterrupted rosette patterns will work as long as fluidic media presence near thecannula 148 will short out a sufficient portion of therosette 246 for a measurable change in impedance to be detectable. Uninterrupted rosettes have a continuous conductive path so that the voltage drop across the rosette is measurable, and is not zero. Thus, a test voltage may be used to confirm that there are no disconnects or opens in the circuit leading from the electronics to the rosette and back. - In some embodiments, the impedance of the fluidic media to be detected, and the impedance of the conductive leads leading from the electronics to the rosette are low compared to the impedance across the rosette. Thus, the high impedance of the rosette decreases rapidly as relatively highly conductive fluidic media spreads across the rosette. In other embodiments, the impedance of the fluidic media and/or the leads is not low compared to the impedance of the rosette, and therefore the electronics are tuned to detect small shifts in the change of the impedance across the rosette.
- In other embodiments, portions of the rosette are designed to dissolve away in the presence of the fluidic media being infused. An example of a particular embodiment of an
uninterrupted rosette 248 with adissolvable portion 250 near thecannula 148 is shown inFIG. 17C . When fluidic media is present, at least a part of thedissolvable portion 250 of therosette 248 dissolves, and the impedance across therosette 248 increases. Indeed, if enough of therosette 248 dissolves, therosette 248 may become an open circuit. This increased impedance is detected by the medical device electronics. In yet other embodiments, many different continuous rosette patterns may be used so long as the dissolvable portion of the rosette substantially surrounds thecannula 148. These embodiments function even if the fluidic media is not conductive. - In other embodiments, the rosette is discontinuous. The conductive path is interrupted and fluidic media near the
cannula 148 is required to close the open circuit. Although many designs of discontinuous rosettes may be used, one embodiment is shown inFIG. 17B . The normal voltage reading across thediscontinuous rosette 252 may be zero. Fluidic media present near thecannula 148 shorts portions of therosette 252 and closes the circuit. The conductive leads, therosette 252, and the fluidic media near thecannula 148 must have sufficiently high conductivity compared to an open circuit for the fluidic media to be detected. In yet other embodiments, a change in capacitance is measured to detect the presence of fluidic media. - In alternative embodiments, the rosette may be in contact with a material that wicks fluidic away from the
cannula 148 and spreads the fluidic across the rosette for an accelerated response. In further embodiments, a wicking material may be used with the chemical reactions described above, to accelerate the reaction or make the resulting product of the reaction more visible. - In other embodiments, electrical power is not supplied to the rosette. Instead, fluidic media reacts with one or more chemical compounds in contact with the rosette. The electrochemical reaction generates an electrical charge, and the voltage measured across a discontinuous rosette increases from zero to a detectable voltage level indicating that the fluidic media is present. In particular embodiments, two
unconnected electrodes FIG. 17B ) are made of different metals and coated with different chemicals. Theelectrodes 256 and 528 are separated by a material such as a hydrogel or other material that is dry before fluidic media presence, yet after fluidic media has wet the hydrogel or other material conducts electricity. For example, either of the electrodes (e.g., 256) may be made of platinum and is coated with HRP and 4-aminoantipyrine. The other electrode (e.g., 258) may be made of silver that is chloridized. When theelectrodes electrodes electrodes - In particular embodiments, the voltage is applied across an LED (not shown) included as part of the medical device, causing the LED to flash when fluidic media is present. In alternative embodiments, the resulting voltage generated across the
electrodes electrodes electrodes electrode 258 is made of platinum and is coated with HRP and 4-aminoantipyrine, and theother electrode 256 is made of silver that is chloridized. In additional embodiments, other discontinuous rosettes are used. - In further embodiments, a change in impedance is detected if the fluid conduit becomes dislodged. For instance, a change in impedance may be detected if the medical device lifts off the patient's skin and the
cannula 148 becomes dislodged from the subcutaneous tissue. A change in impedance may indicate that thecannula 148 is not in the patient's body, and therefore the system is not primed or otherwise not ready for delivery of fluidic media. In particular embodiments, a pair of electrodes are mounted on the medical device to measure impedance across the patient's skin. When one or both electrodes lose contact with the patient's skin, the increased impedance between the electrodes is sensed by medical device electronics indicating that the system is not primed or otherwise not read for delivery of fluidic media. Alternatively, a change in capacitance between the electrodes may be measured to detect when the medical device lifts off the patient's skin. The relative capacitance increases when one or more electrodes lose touch with the patient's skin. - Other embodiments use electrodes located on an exterior of the
cannula 148 to detect whether thecannula 148 is inserted in the patient's body. Body fluid in the subcutaneous tissue is substantially more conductive than infused fluidic media. When the cannula is pulled from the body, the measured impedance across the electrodes on thecannula 148 increases indicating that the system is not primed or otherwise not ready for delivery of fluidic media. Conversely, when thecannula 148 is inserted into the body, the measured impedance across the electrodes on thecannula 148 decreases indicating that thecannula 148 has been inserted. This may further indication that the system is now primed or otherwise ready for delivery of fluidic media. - In yet other embodiments, electrodes may be located on an exterior of any suitable fluid conduit, such as the
needle 124 to detect whether theneedle 124 is properly connected or otherwise position (e.g., in fluid communication with the reservoir 108). Fluidic media has a certain conductance that be measured against an expected value to determine if fluidic media is present or not present. - Particular embodiments include a needle (e.g., 146) centered inside the
cannula 148 as one electrode and a metal sheath on the external surface of thecannula 148 as the other electrode. In alternative embodiments, the electrodes are conductive strips on the external surface of thecannula 148. Other embodiments include a first electrode attached to the cannula and a second electrode touching the surface of the patient's skin. This method is easier to use if thecannula 148 inserted in the patient's body is conductive, such as a steel needle, a cannula with a conductive coating, a cannula with conductors on the exterior surface, or the like. Again, impedance increases when thecannula 148 is removed from the patient's body and impedance decreases when thecannula 148 is inserted in the patient's body. Alternatively, capacitance is measured instead of impedance. In this case, capacitance increases when thecannula 148 is removed from the patient's body, and decreases when thecannula 148 is inserted in the patient's body. - In alternative embodiments, the presence of fluidic media and/or the
cannula 148 may trigger an exothermic chemical reaction. Accordingly, the patient may feel their skin near thecannula 148 become warm when thecannula 148 and/or fluidic media (in the cannula 148) is present. In such embodiments, visual inspection of thecannula 148 is replaced by a tactile temperature change. In other embodiments, both the color change method and an exothermic reaction are used. - Although various embodiments relate to a cannula, other embodiments may relate to any fluid conduit—in addition to or in alternative of the cannula—such as, but not limited to, the
needle 124 that connects thecannula 148 with thereservoir 108, theconnection portion 130, theneedle 146, and/or the like. - Although various embodiments relate to one or more fluid conduits, other embodiments may relate to other components—in addition to or in alternative of the one or more fluid conduits—such as, but not limited to, the
second septum 136 and/or the like. Accordingly, the medical device may detect the presence of thesecond septum 136, as shown, for example, inFIG. 9 . For instance, the medical device may be configured, for example in a manner described above, to detect the second septum 136 (or a reaction occurring therein) when theconnection portion 130 of thereservoir 108 is inserted in thereceptacle structure 110 to allow theneedle 124 to pierce thesecond septum 136, which places theneedle 124 in fluid communication with thereservoir 108. - Further examples of component connection and/or alignment verification structures are described with reference to
FIGS. 18A-20B , wherein amedical device system 900 may incorporate two parts: afirst housing portion 901 and asecond housing portion 902. Other embodiments may include medical device systems with more than two parts. - The
medical device system 900 may be similar to or employed as (but not limited to) an embodiment of the one or more of the medical device systems (e.g.,FIGS. 7A-17C ) discussed in the disclosure. Although themedical device system 900 may include features similar or used with the embodiments ofFIGS. 7A-17C , it should be understood that themedical device system 900 may also include some or all of the same features and operate in a manner similar to that shown and described in the embodiments ofFIGS. 1-6C and/or any of the other embodiments described in the disclosure (e.g.,FIGS. 21A-22B ). In addition, some or all of the features shown inFIGS. 1-17C (and/or any of the other embodiments described in the disclosure) may be combined in various ways and included in the embodiments shown inFIGS. 18A-20B . Likewise, it should be understood that any of the features of the embodiments ofFIGS. 18A-20B may be combined or otherwise incorporated into any of the other embodiments ofFIGS. 18A-20B as well as any other embodiment herein discussed. - In various embodiments, the
first housing portion 901 may be, but is not limited to, any of the housing portions described, such as the durable portion 30 (e.g.,FIGS. 1-6C ). In other embodiments, thefirst housing portion 901 may be, but is not limited to, the disposable portion 20 (e.g.,FIGS. 1-6C ). - Moreover in various embodiments, the
second housing portion 902 may be, but is not limited to, any of the housing portions described, such as the base 21 (inFIGS. 1-6C ). In such embodiments, for example, thesecond housing portion 902 may be secured to skin of a patient-user or otherwise carried by the patient-user (e.g., secured on a belt, clothing, or the like) during operation of themedical device system 900. In other embodiments, thesecond housing portion 902 may be, but is not limited to, thedurable housing portion 30, thedisposable housing portion 20, and/or the like. - The
first housing portion 901 may include a plurality ofelectrical contacts 910 including a first mainelectrical contact 912 and a second mainelectrical contact 916. The plurality ofelectrical contacts 910 may also include one or more otherelectrical contact 914. Theelectrical contacts 910 may me made of any suitable material such as metal, a rubber conductive pad, as well as any other electrical conductor. - In some embodiments, the other
electrical contact 914 may be arranged between the first mainelectrical contact 912 and the second mainelectrical contact 916. However, the otherelectrical contact 914 may be arranged at any suitable location. The otherelectrical contact 914 may be made of the same material as the first mainelectrical contact 912 and/or the second mainelectrical contact 914. In other embodiments, the otherelectrical contact 914 may be made of a different material (e.g., a different conductive material, or a non-conductive material) from the first mainelectrical contact 912 and/or the second mainelectrical contact 914. - The
second housing portion 902 may include ashorting mechanism 920 or the like configured to establish a short or electrical connection with at least some of theelectrical contacts 910 upon connecting thefirst housing portion 901 and thesecond housing portion 902. In some embodiments, theshorting mechanism 920 may establish an electrical connection with at least some of theelectrical contacts 910 in a case where thefirst housing portion 901 and thesecond housing portion 902 are connected properly or otherwise brought into a pre-defined, sufficiently aligned position and/or in a pre-defined, sufficiently close proximity. The predefined aligned position and/or proximity, for example, may correspond to a properly aligned and mutually proximate position for connection of thefirst housing portion 901 and thesecond housing portion 902 for operation. In other embodiments, theshorting mechanism 920 may be a known resistance or the like. - The
shorting mechanism 920 may have afirst end 922 and asecond end 924 for contacting respectiveelectrical contacts 910 on thefirst housing portion 901. In some embodiments, thefirst end 922 and thesecond end 924 may be arranged to contact the first mainelectrical contact 912 and the second mainelectrical contact 916 respectively when thefirst housing portion 901 and thesecond housing portion 902 are connected properly, for example, as shown inFIG. 41B . As such, theshorting mechanism 920 may contact the first mainelectrical contact 912 and the second mainelectrical contact 916, but not the otherelectrical contact 914. Suitable circuitry (not shown) connected to theelectrical contacts 910 may be configured to detect an electrical connection or short between the first mainelectrical contact 912 and the second main electrical contact 916 (via the shorting mechanism 920) indicating a proper connection of thefirst housing portion 901 and thesecond housing portion 902. - Furthermore, the
electrical contacts 910 and/or theshorting mechanism 920 may be arranged on their respective parts such that in a case where thefirst housing portion 901 and thesecond housing portion 902 are not properly connected, such as inFIG. 18C , an electrical connection between the first mainelectrical contact 912 and the second mainelectrical contact 916 is not established. Accordingly, this may indicate that thefirst housing portion 901 and thesecond housing portion 902 have not been connected properly. - Returning to
FIGS. 18A-18C , some embodiments in which at least one otherelectrical contact 914 is arranged between the first mainelectrical contact 912 and the second mainelectrical contact 916 may prevent a false detection of a proper connection of thefirst housing portion 901 and thesecond housing portion 902. For example, the circuitry may be able to distinguish between a case where a stray metal object (e.g., a metal key, paper clip, coin) or other electrical conductor contacts the first mainelectrical contact 912, the second mainelectrical contact 916, and theother contact 914 as opposed to a proper connection where only the first mainelectrical contact 912 and the second mainelectrical contact 912 are contacted (by the shorting mechanism). - In some embodiments, an electrical connection will only be established when the
first end 922 contacts the first mainelectrical contact 912 and thesecond end 924 contacts the second mainelectrical contact 916. In other embodiments, an electrical connection may be established in a case where thefirst end 922 and thesecond end 924 contact the first mainelectrical contact 912 and the second mainelectrical contact 916 respectively or in a case where thefirst end 922 and thesecond end 924 contact the second mainelectrical contact 916 and the first mainelectrical contact 912 respectively. Such embodiments, may allow for a detection of a proper connection of thefirst housing portion 901 and thesecond housing portion 902 in more than one orientation. - In the embodiments shown in
FIGS. 18A-18C , there are three electrical contacts: the first mainelectrical contact 912, the second mainelectrical contact 916, and the otherelectrical contact 914 arranged between the first mainelectrical contact 912 and the second mainelectrical contact 916. However, in various other embodiments, any suitable number ofelectrical contacts 910 may be provided on thefirst housing portion 901 as required. In some embodiments, the main electrical contacts (e.g., 912, 916) are arranged as the outermost electrical contacts; however, in other embodiments, the main electrical contacts may be arranged anywhere relative to the other electrical contact(s) 914. - Similarly, the other electrical contacts need not be limited to being arranged in between main electrical contacts, but may also be arranged to be the outermost electrical contact in some embodiments. As such, the electrical contacts 910 (e.g., main electrical contacts and other electrical contacts) may be arranged or otherwise provided on the
first housing portion 901 in any suitable manner, for example linearly/non-linearly, equidistant/non-equidistant, similar/varying heights, arranged on similar/varying surfaces, same/different resistances, same/different materials, and/or the like. For instance, as shown inFIG. 19 , sevenelectrical contacts 910 could be provided including two first mainelectrical contacts 912, a first otherelectrical contact 914, a second mainelectrical contact 916, a second otherelectrical contact 914, and two third mainelectrical contacts 918. - In the embodiments shown in
FIGS. 18A-18C , theshorting mechanism 920 has twoends electrical contact 912 and the second mainelectrical contact 916, respectively. However, in various other embodiments, theshorting mechanism 920 may be provided with any suitable number of ends or contact surfaces for contacting theelectrical contacts 910 as required. Similarly, the ends (e.g., 922, 924) may be arranged on shortingmechanism 920 in any suitable manner. - In various embodiments, the
electrical contacts 910 may be provided on thefirst housing portion 901 and theshorting mechanism 920 may be provided on thesecond housing portion 902. In other embodiments, theelectrical contacts 910 may be provided on thesecond housing portion 902 and theshorting mechanism 920 may be provided on thefirst housing portion 901. In further embodiments, each of thefirst housing portion 901 and thesecond housing portion 902 may be provided with ashorting mechanism 920 and complementingelectrical contacts 910. - In some embodiments, such as the embodiments shown in
FIGS. 20A and 20B , abias member 919, such as a spring, or the like, may be provided to bias theelectrical contacts 910 either individually, partially (e.g., some, but not all), or collectively toward a first position (e.g., an extended position as shown inFIG. 20A ). As such, theelectrical contacts 910 may be moveable toward a second position (e.g., a retracted position as shown inFIG. 20B ), for example, as thefirst housing portion 901 and thesecond housing portion 902 are brought together. Thus, while in the second position, an electrical connection may be established between the first mainelectrical contact 912 and the second mainelectrical contact 916 via theshorting mechanism 910 in a similar manner to that previously described. Thebias member 919 may be located at least partially within a recess of thefirst housing portion 901. In some embodiments, thebias member 919 may be supported on thefirst housing portion 901, for example, between theelectrical contacts 910 and thefirst housing portion 901. - In addition or in alternative to the above, in some embodiments, a bias member, such as a spring, or the like, may be provided to bias the shorting mechanism or portion thereof (e.g., ends 922, 924) toward a first position (e.g., an extended position). As such, shorting mechanism or portion thereof may be moveable toward a second position (e.g., a retracted position), for example, as the
first housing portion 901 and thesecond housing portion 902 are brought together. Thus, while in the second position, an electrical connection may be established between the first mainelectrical contact 912 and the second mainelectrical contact 916 via theshorting mechanism 910 in a similar manner to that previously described. - In various embodiments, the
electrical contacts 920 and/or theshorting mechanism 910 may be or otherwise comprise a bias member like that previously described. For example, theelectrical contacts 920 may be metal springs or the like that may be moveable from the first position to the second position as thefirst housing portion 901 and thesecond housing portion 902 are brought together. - Further examples of component connection and/or alignment verification structures are described with reference to
FIGS. 21A-22B , wherein amedical device system 1100 may incorporate two parts: afirst housing portion 1101 and asecond housing portion 1102. Other embodiments may include medical device systems with more than two parts. - The
medical device system 1100 may be similar to or employed as (but not limited to) an embodiment of the one or more of the medical device systems (e.g.,FIGS. 7A-20B ) discussed in the disclosure. Although themedical device system 1100 may include features similar or used with the embodiments ofFIGS. 7A-20B , it should be understood that themedical device system 1100 may also include some or all of the same features and operate in a manner similar to that shown and described in the embodiments ofFIGS. 1-6C and/or any of the other embodiments described in the disclosure. In addition, some or all of the features shown inFIGS. 1-20B (and/or any of the other embodiments described in the disclosure) may be combined in various ways and included in the embodiments shown inFIGS. 21A-22B . Likewise, it should be understood that any of the features of the embodiments ofFIGS. 21A-22B may be combined or otherwise incorporated into any of the other embodiments ofFIGS. 21A-22B as well as any other embodiment herein discussed. - In various embodiments, the
first housing portion 1101 may be, but is not limited to, any of the housing portions described, such as the durable portion 30 (e.g.,FIGS. 1-6C ). In other embodiments, thefirst housing portion 1110 may be, but is not limited to, the disposable portion 20 (e.g.,FIGS. 1-6C ). - Moreover in various embodiments, the
second housing portion 1102 may be, but is not limited to, any of the housing portions described, such as the base 21 (FIGS. 1-6C ). In such embodiments, thesecond housing portion 1102 may be secured to skin of a patient-user during operation of themedical device system 1100. In other embodiments, thesecond housing portion 1102 may be, but is not limited to, thedurable housing portion 30, the disposable housing portion, and/or the like. - The
first housing portion 1101 may include asensor 1110 for sensing a magnetic field, and in specific embodiments, for sensing at least a direction (i.e., vector) of a magnetic field.Such sensors 1110 may allow for detecting a presence of a magnetic field or magnetic source independent of magnetic strength. Furthermore, sensing a direction of a magnetic field may increase the probability that thesensor 1110 is sensing the appropriate the magnetic source. Thesensor 1110 may be similar to the sensors described in, but is not limited to, U.S. patent application Ser. No. 12/649,619, filed Dec. 30, 2009, entitled “Alignment Systems and Methods,” herein incorporated by reference in its entirety. Thesensor 1110 may be disposed in thefirst housing portion 1101 or be provided on thefirst housing portion 1101. - Suitable electronics may be connected to the
sensor 1110 to provide a controlled power signal to selectively activate or otherwise control one or more of thesensor 1110 and/or other components as described in the disclosure. For example, thesensor 1110 may be controlled to activate upon a manual activation of a control button, switch, or other manual operator on one of the connectable components or on a remote-controller device (not shown) connected in wireless communication with thesensor 1110 through suitable control electronics. As another example, thesensor 1110 may be controlled to activate automatically after a certain action, such as activation of a button, and/or the like or after a certain amount of time. In some embodiments, thesensor 1110 may be controlled to activate upon activation or insertion of a particular component or device, such as, but not limited to, a needle inserter to insert a needle or cannula. - Examples of various needle insertion tools are described in, but are not limited to, U.S. patent application Ser. No. 11/645,972, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,052, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,000, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method,” all of which are herein incorporated by reference in their entirety. Thus, in such examples, the
sensor 1110 may be activated, for example, before or after, thefirst housing portion 1101 and thesecond housing portion 1102 are brought operatively engaged. - The
second housing portion 1102 may include amagnetic source 1120 or the like for providing a magnetic field having a direction. Themagnetic source 1120 may be arranged on or in thesecond housing portion 1102 at a location to allow the magnetic field and/or the direction of the magnetic field of themagnetic source 1120 to be detectable by thesensor 1110 in a case where the first housing portion and thesecond housing portion 1102 are connected properly or otherwise brought into a pre-defined, sufficiently aligned position and/or in a pre-defined, sufficiently close proximity. The predefined aligned position and/or proximity, for example, may correspond to a properly aligned and mutually proximate position for connection of thefirst housing portion 1101 and thesecond housing portion 1102 for operation. Detection of the magnetic field and/or the direction of the magnetic field of themagnetic source 1120 may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have been connected properly. - In some embodiments, the
magnetic source 1120 may be in contact with thesensor 1110 to allow thesensor 1120 to detect the magnetic field and/or direction of the magnetic field of themagnetic source 1120. In other embodiments, themagnetic source 1120 need not be in contact with thesensor 1110 to allow thesensor 1110 to detect the magnetic field and/or direction of the magnetic field of themagnetic source 1120. For example, a portion of one or both of thefirst housing portion 1101 and thesecond housing portion 1102 may be arranged between thesensor 1110 and themagnetic source 1120. - Furthermore, the
sensor 1110 and themagnetic source 1120 may be arranged such that in a case where thefirst housing portion 1101 and thesecond housing portion 1102 are not been properly connected, thesensor 1110 will not be able to detect the magnetic field and/or the direction of the magnetic field, for example, because thesensor 1110 and themagnetic source 1120 are too far apart. Accordingly, this may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have not been connected properly. - In some embodiments, the
magnetic source 1120 may provide more than one magnetic fields and/or directions of magnetic fields. As shown for example inFIGS. 21A and 21B , afirst field 1122, asecond field 1124, and athird field 1126 are provided in which thefirst field 1122 and thethird field 1126 have a direction different from a direction of thesecond field 1124. In such an example, thesensor 1110 may be configured to detect only thesecond field 1124 and/or the direction (e.g., North) of thesecond field 1124 in a manner previously described. Thus, detection of thesecond field 1124 and/or the direction of thesecond field 1124 may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have been connected properly. - In further embodiments, the
sensor 1110 may be configured to detect other fields (e.g.,first field 1122 and second field 1126) and/or directions of the other fields such that detection of the other fields and/or directions of the other fields may indicate an improper connection of thefirst housing portion 1101 and thesecond housing portion 1102. The electronics may employ an algorithm for processing information relating to the various fields and/or other related information (e.g., magnetic field strength, gauss level, and/or the like). - In some embodiments, such as the embodiments shown in
FIGS. 22A-22B , thefirst housing portion 1101 may have asensor 1111 for sensing a gauss level or the like of a magnetic source. Thesensor 1111 may be similar to thesensor 1110 previously described or any of the sensors described in, but is not limited to, U.S. patent application Ser. No. 12/649,619, filed Dec. 30, 2009, entitled “Alignment Systems and Methods,” herein incorporated by reference in its entirety. Thesensor 1111 may be disposed in thefirst housing portion 1101 or be provided on thefirst housing portion 1101. - Suitable electronics may be connected to the
sensor 1111 to provide a controlled power signal to selectively activate or otherwise control one or more of thesensor 1111 and/or other components as described in the disclosure. For example, thesensor 1111 may be controlled to activate upon a manual activation of a control button, switch, or other manual operator on one of the connectable components or on a remote-controller device (not shown) connected in wireless communication with thesensor 1111 through suitable control electronics. As another example, thesensor 1111 may be controlled to activate automatically after a certain action, such as activation of a button, and/or the like or after a certain amount of time. In some embodiments, thesensor 1111 may be controlled to activate upon activation or insertion of a particular component or device, such as, but not limited to, a needle inserter to insert a needle or cannula. - Examples of various needle insertion tools are described in, but are not limited to, U.S. patent application Ser. No. 11/645,972, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,052, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/645,435, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method”; U.S. patent application Ser. No. 11/646,000, filed Dec. 26, 2006, “Infusion Medium Delivery System, Device And Method With Needle Inserter And Needle Inserter Device And Method,” all of which are herein incorporated by reference in their entirety. Thus, in such examples, the
sensor 1111 may be activated, for example, before or after, thefirst housing portion 1101 and thesecond housing portion 1102 are brought operatively engaged. - The
second housing portion 1102 may include amagnetic source 1121 or the like for providing a certain gauss level. Themagnetic source 1121 may be similar to themagnetic source 1120 previously described or any of the magnetic sources described in, but is not limited to, U.S. patent application Ser. No. 12/649,619, filed Dec. 30, 2009, entitled “Alignment Systems and Methods,” herein incorporated by reference in its entirety. - The
magnetic source 1121 may be arranged on or in thesecond housing portion 1102 at a location to allow the gauss level of themagnetic source 1121 to be detectable and/or measurable by thesensor 1110 in a case where the first housing portion and thesecond housing portion 1102 are connected properly. Detection of gauss level of themagnetic source 1121 may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have been connected properly. In further embodiments, thesensor 1111 and/or associated electronics may be configured to detect a gauss level that is within a specified range. In such embodiments, a gauss level that is below or exceeds the specified range may indicate an improper connection. - In some embodiments, the
magnetic source 1121 may be in contact with thesensor 1111 to allow thesensor 1111 to detect the gauss level of themagnetic source 1121. In other embodiments, themagnetic source 1121 need not be in contact with thesensor 1111 to allow thesensor 1111 to detect the gauss level of themagnetic source 1121. For example, a portion of one or both of thefirst housing portion 1101 and thesecond housing portion 1102 may be arranged between thesensor 1111 and themagnetic source 1121. - Furthermore, the
sensor 1111 and themagnetic source 1121 may be arranged such that in a case where thefirst housing portion 1101 and thesecond housing portion 1102 are not been properly connected, thesensor 1111 will not be able to detect the gauss level (or the gauss level is not within a detectable range) of themagnetic source 1121, for example, because thesensor 1111 and themagnetic source 1121 are too far apart. Accordingly, this may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have not been connected properly. - In further embodiments, electronics (not shown), such as a magnetic threshold switch (e.g., hall switch, reed switch, and/or the like), or the like, associated with the
sensor 1111 may be configured to provide a signal or the like upon the sensor 1111 (or other sensor) sensing a signal outside a second range, which in some embodiments may be the same the specified range. In other embodiments, the second range may be different from the specified range. For example, the electronics may provide a signal to the control electronics of themedical device system 1100 to disable themedical device system 1100 or certain portions thereof if a gauss level beyond the second range is detected. Such embodiments may protect the various electronics of themedical device system 1100 in a case where themedical device system 1100 is in operation and is exposed to a strong external magnetic influence, such as an MRI (magnetic resonance imaging) machine, or the like. - In some embodiments, the
magnetic source 1121 may provide more than one gauss level. In such embodiments, thesensor 1111 may be configured to detect only a particular gauss level corresponding to a proper connection of thefirst housing portion 1101 and thesecond housing portion 1102 similar to a manner previously described. Thus, detection of the particular gauss level may indicate that thefirst housing portion 1101 and thesecond housing portion 1102 have been connected properly. In further embodiments, thesensor 1111 may be configured to detect other gauss levels such that detection of the other gauss levels may indicate an improper connection of thefirst housing portion 1101 and thesecond housing portion 1102. The electronics may employ an algorithm for processing information relating to the various gauss levels and/or other related information (e.g., magnetic field strength, direction of a field, and/or the like). - With reference to
FIGS. 22A-22B , in various embodiments, thesensor 1110 and thesensor 1111 may be the same sensor and thus may be configured to sense both a direction of magnetic field and a gauss level from a magnetic source. In some embodiments, thesensor 1110 and thesensor 1111 may both provided for sensing a magnetic source (e.g., 1120, 1121) as previously described. Thesensor 1110 and thesensor 1111 may be arranged to sense the same magnetic source or respective magnetic sources. In further embodiments, the electronics may employ an algorithm for processing information relating to the various gauss levels, field directions, and/or other related information. - In various embodiments, the
sensor first housing portion 1101 and themagnetic source second housing portion 1102. In other embodiments, thesensor second housing portion 1102 and themagnetic source first housing portion 1101. In further embodiments, each of thefirst housing portion 1101 and thesecond housing portion 1102 may be provided with a sensor (e.g., 1110, 1111) and complementing magnetic source (e.g., 1120, 1121). - With reference to
FIGS. 18A-22B and 23, the sensors and/or the electrical contacts may be in electrical communication with electronics (not shown). The electronics may be incorporated within control electronics for controlling a drive device 44 (e.g.,FIG. 4 ) such as, but not limited to, control electronics 52 (e.g.,FIG. 4 ) for controlling the drive device 44. Alternatively, the electronics may be separate from and in addition to thecontrol electronics 52, but connected in electrical communication with thecontrol electronics 52 and/or the drive device 44 to provide a drive control signal to the drive device 44. More specifically, the electronics may be configured to inhibit operation of the drive device 44, unless a signal or a change in state is received by thecontrol electronics 52. - For instance, as previously discussed, a signal or a change in state may be provided upon the
first end 922 and thesecond end 924 interacting with the firstmain contact 912 and the secondmain contact 916, for example, in a case where thefirst housing portion 901 and thesecond housing portion 902 are in proper alignment and sufficiently close in proximity to connect for operation. In other words, the drive device 44 may be inoperable unless thefirst housing portion 901 and thesecond housing portion 902 are operatively engaged properly (i.e., aligned and/or connected properly). - The electronics and/or the control electronics 52 (e.g.,
FIG. 4 ) may be configured to control the drive device 44 (e.g.,FIG. 4 ) in various manners in accordance with various embodiments of the invention. Examples are discussed in, but are not limited to, U.S. patent application Ser. No. 11/759,725, entitled “Infusion Medium Delivery Device and Method with Drive Device for Driving Plunger in Reservoir”; and U.S. patent application Ser. No. 12/649,619, filed Dec. 30, 2009, entitled “Alignment Systems and Methods,” both of which are herein incorporated by reference in their entirety. - For example, the drive device 44 may be controlled to stop pumping (delivery) operation upon a detection of an interruption of a fluid-flow path or a disconnection of a critical component in the medical device system (e.g., 900, 1100). These may include, but are not limited to, a disconnection of a housing portion from another housing portion or from a base portion, a disconnection of a conduit from another conduit or from a reservoir, a disconnection of a reservoir from a housing portion or a base, and/or the like.
- In yet further embodiments, additional sensors may be provided within the medical device system and connected for electrical communication with the electronics 414. Such additional sensors may comprise magnetically and/or electronically actuating switches, magnetic and/or electric field magnitude and direction sensors, inductive sensors, other proximity sensors, contact sensors, and/or the like for providing a detectable signal or change in a state upon proper connection of other components in the medical device system. Such proper connection of other components may comprise, for example, one or more of a proper connection of a reservoir into a housing portion or base, a proper connection of a conduit to a reservoir, a proper connection of two conduits together, a proper setting of a needle or cannula in an inserted state, a proper connection of a conduit to a cannula or needle, or a proper connection of other components of or to the medical device system.
- In alternative or in addition, the electronics and/or the control electronics 52 (e.g.,
FIG. 4 ) may be configured to detect a first-time connection of a first housing portion (e.g., 901) and a second housing portion (e.g., 902) or a first-time connection of other components, as compared to a re-connection after previous or partial usage. In this manner, the drive device 44 may be controlled to provide a priming operation or other suitable first-time operation(s) upon detection of a first-time connection of the first part 401 and the second part 402. - In various embodiments, the sensors, electrical contacts, and/or associated circuitry may allow for, but is not limited to, tracking a number of times a component has been connected to and/or disconnected from other components, verifying proper connection and/or alignment of components in a medication delivery system prior to each delivery step, checking, sensing, and/or measuring parameters, such as ambient parameters (e.g., ambient magnetic fields), operating parameters, and/or the like, alerting users to conditions, such as conditions outside operating parameters of the delivery system, and/or the like.
- Various embodiments may allow for verification between two (or more) distinct and separate components, verification of correct positioning between the two (or more) distinct and separate components, verification that the two (or more) distinct and separate components have been connected in the correct order, a safety mechanism to provide notification of separation (intentional or accidental) of any individual component in a multi-component system, and/or the like.
- In alternative or in addition, the electronics and/or the control electronics 52 (e.g.,
FIG. 4 ) may be configured to provide a user-perceptible indication of a proper alignment and/or connection of the first housing portion and the second housing portion or of other components. For example, upon detection of a proper alignment and/or connection of the first housing portion and the second housing portion 402, the electronics 414 and/or thecontrol electronics 52 may provide a suitable control signal to activate anindicator device 420, as shown inFIG. 36 . - The
indicator device 420 may be operated by aprocessor 422. Theprocessor 422 may be configured to execute various programs and/or to process various information, such as data received from one or more sensors, responsive devices, and/or other interactive elements. Theprocessor 422, for example, may be configured to compare detected signals with thresholds and/or pre-stored values inmemory 424. - With reference to
FIGS. 18A-22B and 23, theindicator device 420 may include, but is not limited to, an audible indicator, an optical indicator, a tactile indicator, combinations of one or more those indicators, and/or the like. For example, upon a proper alignment or connection of components as described above, an audible beeping sound or other suitable sound may be generated by a sound generating device in or associated with one or both of the first housing portion and the second housing portion. For example, upon a proper alignment or connection of components as described above, a flashing light or other suitable visual indicator may be generated by an LED or other light source or a display device on or associated with one or both of the first housing portion and the second housing portion. For example, upon a proper alignment or connection of components as described above, a vibration and/or the like may be generated by a vibration device and/or the like in or associated with one or both of the first housing portion and the second housing portion. Examples of indicator devices are discussed in, but are not limited to, U.S. patent application Ser. No. 11/759,725, entitled “Infusion Medium Delivery Device and Method with Drive Device for Driving Plunger in Reservoir”; and U.S. patent application Ser. No. 12/649,619, filed Dec. 30, 2009, entitled “Alignment Systems and Methods,” both of which are herein incorporated by reference in their entirety. - Throughout various embodiments, a medical device system includes multiple housing portions that must be put together. The medical device system must be able to verify presence of the housing portions and alignment of the housing portions relative to each other. In particular embodiments, the medical device system is configured to detect proper alignment between one or more housings, for example between the base 21 (refer to
FIGS. 1-6C ) and the durable housing portion 30 (refer toFIGS. 1-6C ).FIG. 24 illustrates an alignment verification process S2400 implemented by a medical device system having thestructures FIGS. 18A-22B for detecting proper alignment between a first housing portion (e.g.,durable housing portion 901, 1101) and a second housing portion (e.g.,base portion 902, 1102). - With reference to
FIGS. 18A-24 , the process S2400 typically (but not necessarily) takes place when the medical device system is in a monitoring state, waiting for confirmation of a fully assembled medical device system to begin normal operation. - The process S2400 algorithm is triggered by an interrupt (S2410), which is detected when the electrical contacts (e.g., 912 and 916) switch states (e.g., from high to low or low to high) (S2412). To account for system instability and reduce false interrupts, the medical device system continues to monitor the interrupt line (BP_INT) for a period of time (S2414). This ensures that the electrical contacts remain in the states for a minimum specified duration (e.g., 100 ms). Any intermediate interrupt will reset the timer.
- Next, the system determines whether the interrupt (BP_INT) was triggered by the base housing portion and not, for example, by a short from an ionic solution, partial short, or a disconnection of the base housing portion from the durable housing portion. In particular, in step S2420, state of the other electrical contact (e.g., 914) is monitored. In a case where the states of the
electrical contacts electrical contact 914 is HIGH (i.e., a same state as that of the electrical contacts) (S2422: NO), a partial short, ionic solution presence, or disconnection of the housing portion may have occurred, which may indicate that the medical device system components are disconnected or otherwise not in a state for operation (S2424). Accordingly, the medical device system, in step S2426, may provide an alarm or other indication of such, for example via theindicator 420. - In a case where the states of the
electrical contacts electrical contact 914 is NO (i.e., an opposite or different state as the electrical contacts) (S2422: YES), the system determines whether the interrupt (BP_INT) was triggered by the base housing portion and not, for example, a metallic short. In particular, in step S2430, a voltage pulse may be applied. Then in step S2432, a reference state is detected. If the reference state is LOW (i.e., an opposite or different state as the electrical contacts) (S2434: NO), a metallic short may have occurred, which may indicate that the medical device system components are disconnected or otherwise not in a state for operation (S2436). Accordingly, the medical device system, in step S2438, may provide an alarm or other indication of such, for example via theindicator 420. - If the reference state is HIGH (i.e., a same state as the electrical contacts) (S2434: YES), the magnetic sensor (e.g., 1110, 1111) is queried to verify alignment of the connected housing portions. In particular, in step S2440, the magnetic sensor samples (e.g., 16×@1 kHz) the magnetic source (e.g., 1120, 1121). In some embodiments, in step S2442, an averaging filter may be implemented to adjust the sampled sensor data, for example to mitigate spurious signals, attenuate noise, adjust sampled sensor data to mitigate anomalous data points, and/or the like. In step S2444, the sampled sensor data (or adjusted sampled sensor data) is compared to a table or predetermined range of values to determine whether the sensor and the magnetic source (and thus the durable housing portion and the base housing portion, respectively) are aligned in the predetermined manner. If the sensor data is not within the range of values (S2446: NO), this may indicate that the medical device system components are disconnected or otherwise not in a state for operation (S2447). Accordingly, the medical device system, in step S2448, may provide an alarm or other indication of such, for example via the
indicator 420. If the sensor data is within the range of value (S2446: YES), this may indicate that the housing portions are connected and aligned in the predetermined manner (S2450) to allow the medical device system to begin normal operation (e.g., begin delivery of insulin). - In particular embodiments, the magnetic sensor is a magnetic angle sensor that measures a magnetic angle of the magnetic source to determine whether the measured magnetic angle is within a predetermined range, which would indicate that housing portions are aligned in the predetermined manner. When the measured magnetic angle is outside the predetermined range, this may indicate that the base portion is not present or that the housing portions are not otherwise aligned. In other embodiments, a reed switch may be used in place of the magnetic angle sensor. The reed switch may generate an interrupt any time the base portion is moved to act as a signal for change in base proximity.
- In various embodiments, one or more of the steps of the process S2400 may be omitted, added to, or replaced. For instance, in some embodiments, the triggered interrupt (S2410) may trigger programmed sampling of the contact potential (or the like) at one or more specified intervals. If sample n does not match the original detected interrupt, the triggered interrupt is cleared, and the process waits for a new interrupt. In other embodiments, the algorithm may be triggered (e.g., steps S2410-S2414) through use of the magnetic sensor. For instance, the sensor may continuously monitor the magnetic field of the magnetic source, and may trigger the algorithm whenever the sensor data is within the predetermined range of values. In some embodiments, the verification steps (e.g., steps S2420-S2446) may be omitted. In other embodiments, only one or two of the ionic solution check, metallic short check, and magnetic sensor check may be performed. In various embodiments, upon each failure, the system may alert the user of the corresponding failure and end the process S2400. In other embodiments, the system may continue some or all of the steps of the process S2400 after a failure has been determined, and then issue one or more alerts corresponding the failure and any other failures. In various embodiments, a failure alert is issued more or less immediately after occurring. In other embodiments, the failure alerts are delayed until some later event. For instance, the alert may be issued at a later time when the user attempts to operate a motor of the medical device system.
- In various embodiments, the process 2400 verifies that the base portion is presented (i.e., that the components are properly aligned). In other embodiments, the process 2400 may be used (and modified accordingly) in a similar manner to determine that the base portion is not present. This may be useful when ensuring engagement of the drive system to the delivery system, resetting drive components, or otherwise calibrating the medical device system.
-
FIG. 25 illustrates an alignment monitoring process S5400 implemented by a medical device system having thestructures FIGS. 18A-22B for detecting proper alignment between a first housing portion (e.g.,durable housing portion 901, 1101) and a second housing portion (e.g.,base portion 902, 1102). - With reference to
FIGS. 18A-25 , the process S2500 typically (but not necessarily) begins with a system request (S2510) that takes place after the components of the medical device system have been properly aligned, for example (but not limited to), upon completion of step S2450. The system request may occur immediately upon completion of step S2450, periodically (e.g., every 5 minutes) thereafter, or upon the occurrence of an event (e.g., an interrupt on the other electrical contact is triggered). - Next, the magnetic sensor (e.g., 1110, 1111) is queried to verify alignment of the connected housing portions, for example as described in S2400. In particular, in step S2520, the magnetic sensor samples (e.g., 16×@1 kHz) the magnetic source (e.g., 1120, 1121). In some embodiments, in step S2522, an averaging filter may be implemented to adjust the sampled sensor data, for example to adjust sampled sensor data to mitigate anomalous data points, attenuate noise, mitigate spurious signals, and/or the like. In step S2524, the sampled sensor data (or adjusted sampled sensor data) is compared to a table or predetermined range of values to determine whether the sensor and the magnetic source (and thus the durable housing portion and the base housing portion, respectively) are aligned in the predetermined manner. If the sensor data is within the range of value (S2426: YES), this may indicate that the housing portions are connected and aligned in the predetermined manner (S2450) to allow the medical device system to begin normal operation (e.g., begin delivery of insulin).
- If the sensor data is not within the range of values (S2426: NO), the system may wait a period of time (S2530) (e.g., 500 ms) to determine if an interrupt is triggered (S2532), after which the interrupt behavior may be followed. If the interrupt is triggered (S2532: YES), this may indicate that the medical device system components have become disconnected or are otherwise not in a state for operation (S2534). Accordingly, the medical device system, in step S2536, may provide an alarm or other indication of such, for example via the
indicator 420. If no interrupt occurs (S2532: NO), the check may be repeated at least one more time (S3538: NO). If the check continues to fail (S2538: YES), normal operation is halted and the user is notified (S2534, S2536). - In various embodiments, the medical device system implements process S2400 to verify an initial connection and/or alignment of the durable housing portion and the base portion (or between other suitable housing portions), and then implements the process S2500 to continuously monitor that the housing portions remain connected and/or aligned. In other embodiments, one of these processes may be omitted. For instance, once the process S2400 is complete, the medical device system need not execute the process S2500.
- In some embodiments, a single failure of the sensor (e.g., S2526: NO) may be sufficient to indicate a failure. Thus, in some embodiments, at least steps S2532 and S2538 and/or any other verification steps may be omitted.
- In some embodiments, the verification steps using the magnetic sensor (steps S2520-S2526) may in the alternative (or additionally) poll the sensor at one or more specified intervals. If sample n does not match an expected reading, steps S2530-S2538 may follow. If the same sample does match, the process proceeds to step S2528.
- In some embodiments, a reed switch may be used in place of the magnetic angle sensor. The reed switch may generate an interrupt any time the base portion is moved to act as a signal for change in base proximity.
- In various embodiments, the process S2500 (and/or the process S2400) may verify that a fluid connector (e.g.,
cannula 148 inFIGS. 7-17C ) is properly positioned, as described (but not limited to) any one of the structures and/or methods described with respect toFIGS. 7-17C . For instance, an optical receiver positioned to detect light (and/or other parameters) from the cannula may provide a signal or other indication as part of the process S2500 to indicate whether the cannula is properly positioned. - The embodiments disclosed herein are to be considered in all respects as illustrative, and not restrictive of the invention. The present invention is in no way limited to the embodiments described above. Various modifications and changes may be made to the embodiments without departing from the spirit and scope of the invention. The scope of the invention is indicated by the attached claims, rather than the embodiments. Various modifications and changes that come within the meaning and range of equivalency of the claims are intended to be within the scope of the invention.
Claims (52)
1. A fluidic media detection system for detecting a presence of fluidic media, the system comprising:
a first housing portion adapted to be carried by a user;
a second housing portion configured to be selectively operatively engaged with and disengaged from the first housing portion, the second housing portion for supporting a reservoir having an interior volume for containing fluidic media;
a fluid conduit supported by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged; and
at least one interactive element, positioned near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.
2. The system of claim 1 , wherein the fluid conduit comprises a cannula for insertion into the skin of the user to allow the fluidic media to flow into the body of the user.
3. The system of claim 1 , wherein the fluid conduit provides fluid communication between the reservoir and a cannula for insertion into the skin of the user to allow the fluidic media to flow into the body of the user.
4. The system of claim 1 , wherein the fluid conduit is supported by the first housing portion.
5. The system of claim 1 , wherein the at least one interactive element comprises at least one sensor arranged to detect a parameter or the characteristic of the fluidic media when the fluidic media is in the fluid conduit, the at least one sensor configured to provide an output signal indicating that the fluidic media is detected in the fluid conduit.
6. The system of claim 5 , the system further comprising:
an indication device controlled by the output signal to notify the user when fluidic media is detected.
7. The system of claim 5 , wherein the indicator device produces one of an audible and tactical feedback when fluidic media is detected.
8. The system of claim 1 , wherein the at least one interactive element comprises at least one electrical component configured to detect a change in at least one electrical characteristic of the fluid conduit or the fluidic media when the fluidic media is present in the fluid conduit, the at least one electrical component configured to provide an output signal indicating that the fluidic media is detected in the fluid conduit.
9. The system of claim 1 , wherein the at least one interactive element comprises at least one optical receiver configured to detect a change in light when the fluidic media is in the fluid conduit, the at least one optical receiver configured to provide an output signal indicating that fluidic media is detected in the fluid conduit.
10. The system of claim 1 , wherein the at least one interactive element comprises at least one reactive element, positioned near a portion of the fluid conduit, that reacts with at least one component within or characteristic of the fluidic media when the fluidic media is present in the fluid conduit.
11. The system of claim 10 , wherein the at least one reactive element comprises at least one chemical, positioned near the fluid conduit, that reacts with at least one component within the fluidic when the fluidic media is present in the fluid conduit.
12. The system of claim 11 , wherein a product of a chemical reaction, between the at least one chemical and the at least one component within the fluidic media, is a colored complex.
13. The system of claim 12 , the system further comprising:
an optical receiver configured to detect a change in light when the colored complex is created by the chemical reaction, the optical receiver configured to provide an output signal indicating that fluidic media is detected.
14. The system of claim 13 , the system further comprising:
a light conducting element that guides light from a point near the fluid conduit to the optical receiver.
15. The system of claim 14 , wherein the light conducting element is at least one fiber optic cable.
16. The system of claim 14 , wherein the light conducting element is a fluid connector in communication with the fluid conduit.
17. The system of claim 11 , wherein the at least one chemical is embedded in the fluid conduit.
18. The system of claim 11 , wherein the fluid conduit is impregnated with the at least one chemical.
19. The system of claim 1 , the system further comprising:
a rosette positioned near the fluid conduit;
wherein the at least one interactive element comprises at least one electrical component coupled to the rosette to detect a change in at least one electrical characteristic associated with the rosette when fluidic media is present in the fluid conduit.
20. The system of claim 19 , wherein the rosette is a closed circuit, such that impedance across the rosette decreases as fluidic media nears the fluid conduit.
21. The system of claim 19 , wherein the rosette is an open circuit, such that the circuit is closed when fluidic media nears the fluid conduit.
22. The system of claim 19 , wherein the at least one electrical component detects voltage across the rosette.
23. The system of claim 19 , wherein the at least one electrical component detects impedance across the rosette.
24. The system of claim 19 , wherein the at least one electrical component detects capacitance across the rosette.
25. The system of claim 19 , the system further comprising:
an indication device coupled to the electrical component to notify the user when fluidic media is detected.
26. The system of claim 25 , wherein the indicator device produces one of an audible and tactical feedback when fluidic media is detected.
27. The system of claim 19 , wherein the rosette surrounds an exterior surface of the fluid conduit, an interior surface of the fluid conduit in contact with fluidic media when the fluidic media is in the fluid conduit.
28. A method of manufacturing a fluidic media detection system for detecting a presence of fluidic media, the method comprising:
adapting a first housing portion to be carried by a user;
configuring a second housing portion to be selectively operatively engaged with and disengaged from the first housing portion, the second housing portion for supporting a reservoir having an interior volume for containing fluidic media;
supporting a fluid conduit by one of the first housing portion and the second housing portion for providing fluid communication between the reservoir and the user when the first housing portion and the second housing portion are operatively engaged; and
positioning at least one interactive element near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit.
29. A medical device for treating a user, the medical device comprising:
a first housing portion adapted to be carried by a user;
a second housing portion configured to be selectively operatively engaged with and disengaged from the first housing portion;
a plurality of electrical contacts provided on at least one of the first housing portion and the second housing portion, the plurality of electrical contacts including a set of main electrical contacts and at least one other electrical contact;
a shorting mechanism provided on the other of the first housing portion and the second housing portion, the shorting mechanism for interacting with the set of main electrical contacts;
a magnetic source having at least one of a certain magnetic field and a certain magnetic strength provided on at least one of the first housing portion and the second housing portion;
a sensor for detecting at least one of the certain magnetic field and the certain magnetic strength provided on the other of the first housing portion and the second housing portion; and
electronic circuitry configured to provide a first signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the set of main electrical contacts of the plurality of electrical contacts;
the electronic circuitry configured to provide a second signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts;
the electronic circuitry configured to provide a first sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of the certain magnetic field and the certain magnetic strength of the magnetic source; and
the electronic circuitry configured to provide a second sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of a magnetic field different from the certain magnetic field and a magnetic strength different from the certain magnetic strength of the magnetic source.
30. The device according to claim 29 , the device further comprising:
a user-perceptible indicator operatively coupled to the electronic circuitry for providing a user-perceptible indication in response to receiving one or more of the first signal, the second signal, the first sensing signal, and the second sensing signal.
31. The device according to claim 30 , wherein the user-perceptible indication comprises at least one of an audible indication, a visual indication, and a tactile indication.
32. The device according to claim 30 , wherein the user-perceptible indicator provides a first type of indication when the first sensing signal is received from the electronic circuitry and a second type of indication when at least one of the second signal and the second sensing signal is received from the electronic circuitry.
33. The device according to claim 29 , the device further comprising:
a drive device supported by one of the first housing portion and the second housing portion, the drive device for selectively driving fluid from a reservoir;
wherein the delivery device further comprises control electronics operatively coupled to the electronic circuitry for controlling the drive device based upon receiving one or more of the signals from the electronic circuitry.
34. The device according to claim 33 , wherein the control electronics is configured to inhibit operation of the drive device unless the first sensing signal is received.
35. The device according to claim 33 , wherein the control electronics is configured to begin operation of the drive device upon receiving the first sensing signal.
36. The device of claim 33 , the electronic circuitry configured to provide the first sensing signal for activating the control circuitry in a case where the sensor detects a gauss level exceeding a first pre-defined threshold value.
37. The device of claim 36 , wherein the sensor comprises a magnetic threshold switch.
38. The device of claim 29 ,
the magnetic source having a certain magnetic field direction;
the sensor for detecting the certain magnetic field direction;
the electronic circuitry configured to provide the first sensing signal when the sensor detects the certain magnetic field direction.
39. The device of claim 38 , the electronic circuitry configured to provide the second sensing signal when the sensor detects a magnetic field direction different from the certain magnetic field direction.
40. The device of claim 29 , wherein the certain magnetic field includes a direction, the sensor configured for detecting the direction.
41. The device of claim 29 , wherein the first signal causes the sensor to begin detecting the at least one of the certain magnetic field and the certain magnetic strength.
42. The device of claim 29 ,
wherein the set of main electrical contacts interact with the shorting mechanism when the shorting mechanism contacts the set of main electrical contacts;
the electronic circuitry configured to provide the first signal when the shorting mechanism contacts the set of main electrical contacts of the plurality of electrical contacts;
the electronic circuitry configured to provide the second signal when the shorting mechanism contacts the at least one other electrical contact of the plurality of electrical contacts.
43. The device of claim 29 ,
the shorting mechanism having a plurality of ends, each of the ends for interacting with a respective main electrical contact of the set of main electrical contacts;
the electronic circuitry configured to provide the first signal when each of the ends of the shorting mechanism interacts with the respective main electrical contact of the set of main electrical contacts;
the electronic circuitry configured to provide the second signal when at least one of the ends of the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts.
44. The device of claim 43 ,
the set of main electrical contacts comprising a first main electrical contact and a second main electrical contact;
the plurality of ends of the shorting mechanism including a first end and a second end for interacting with the first main electrical contact and the second main electrical contact;
the electronic circuitry configured to provide the first signal when the first end and the second end of the shorting mechanism interacts with the first main electrical contact and the second main electrical contact of the plurality of electrical contacts;
the electronic circuitry configured to provide the second signal when at least one of the first end and the second end of the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts.
45. The device of claim 29 , wherein at least one of the at least one other electrical contact is arranged between the set of main electrical contacts.
46. The device of claim 29 , wherein at least some of the set of main electrical contacts are arranged to be outermost electrical contacts of the plurality of electrical contacts.
47. The device of claim 29 , wherein all of the at least one other electrical contact is arranged in between the set of main electrical contacts.
48. The device of claim 29 , wherein the shorting mechanism is configured to establish an electrical connection between the set of main electrical contacts when the shorting mechanism interacts with the set of main electrical contacts.
49. The device of claim 29 , the device further comprising:
a fluid conduit supported by one of the first housing portion and the second housing portion in a position to establish fluid communication between a reservoir, supported by one of the first housing portion and the second housing portion, and the user when the first housing portion and the second housing portion are operatively engaged; and
at least one interactive element, positioned near a portion of the fluid conduit, that interacts with the fluidic media when the fluidic media is present in the fluid conduit;
the circuitry configured to provide a first positioning signal in a case where the first housing portion and the second housing portion are brought together and the at least one interactive element interacts with the fluidic media when the fluidic media is present in the fluid conduit.
50. The device according to claim 49 , the device further comprising:
a drive device supported by one of the first housing portion and the second housing portion, the drive device for selectively driving fluidic media from the reservoir;
wherein the delivery device further comprises control electronics operatively coupled to the electronic circuitry for controlling the drive device based upon receiving one or more of the signals from the electronic circuitry.
51. The device according to claim 50 , wherein the control electronics are configured to begin operation of the upon receiving the first positioning signal.
52. A method of manufacturing a medical device for treating a user, the method comprising:
adapting a first housing portion to be carried by a user;
configuring a second housing portion to be selectively operatively engaged with and disengaged from the first housing portion;
providing a plurality of electrical contacts on at least one of the first housing portion and the second housing portion, the plurality of electrical contacts including a set of main electrical contacts and at least one other electrical contact;
providing a shorting mechanism on the other of the first housing portion and the second housing portion, the shorting mechanism for interacting with the set of main electrical contacts;
providing a magnetic source having at least one of a certain magnetic field and a certain magnetic strength on at least one of the first housing portion and the second housing portion;
providing a sensor for detecting at least one of the certain magnetic field and the certain magnetic strength on the other of the first housing portion and the second housing portion;
configuring electronic circuitry to provide a first signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the set of main electrical contacts of the plurality of electrical contacts;
configuring the electronic circuitry to provide a second signal in a case where the first housing portion and the second housing portion are brought together and the shorting mechanism interacts with the at least one other electrical contact of the plurality of electrical contacts;
configuring the electronic circuitry to provide a first sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of the certain magnetic field and the certain magnetic strength of the magnetic source;
configuring the electronic circuitry to provide a second sensing signal in a case where the first housing portion and the second housing portion are brought together and the sensor detects at least one of a magnetic field different from the certain magnetic field and a magnetic strength different from the certain magnetic strength of the magnetic source.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/462,752 US20120215163A1 (en) | 2009-12-30 | 2012-05-02 | Sensing systems and methods |
US13/900,463 US9518813B2 (en) | 2009-12-30 | 2013-05-22 | Sensing systems and methods |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/650,287 US8858500B2 (en) | 2009-12-30 | 2009-12-30 | Engagement and sensing systems and methods |
US12/650,378 US8998840B2 (en) | 2009-12-30 | 2009-12-30 | Connection and alignment systems and methods |
US13/235,288 US8435209B2 (en) | 2009-12-30 | 2011-09-16 | Connection and alignment detection systems and methods |
US201161561801P | 2011-11-18 | 2011-11-18 | |
US13/462,752 US20120215163A1 (en) | 2009-12-30 | 2012-05-02 | Sensing systems and methods |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/650,378 Continuation-In-Part US8998840B2 (en) | 2009-12-29 | 2009-12-30 | Connection and alignment systems and methods |
US12/650,287 Continuation-In-Part US8858500B2 (en) | 2009-12-29 | 2009-12-30 | Engagement and sensing systems and methods |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/900,463 Division US9518813B2 (en) | 2009-12-30 | 2013-05-22 | Sensing systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120215163A1 true US20120215163A1 (en) | 2012-08-23 |
Family
ID=47192230
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/462,752 Abandoned US20120215163A1 (en) | 2009-12-30 | 2012-05-02 | Sensing systems and methods |
US13/900,463 Active 2031-12-13 US9518813B2 (en) | 2009-12-30 | 2013-05-22 | Sensing systems and methods |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/900,463 Active 2031-12-13 US9518813B2 (en) | 2009-12-30 | 2013-05-22 | Sensing systems and methods |
Country Status (2)
Country | Link |
---|---|
US (2) | US20120215163A1 (en) |
WO (1) | WO2013074418A2 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110054399A1 (en) * | 2009-09-02 | 2011-03-03 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20110160655A1 (en) * | 2009-12-30 | 2011-06-30 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US20110160678A1 (en) * | 2009-12-29 | 2011-06-30 | Medtronic Minimed, Inc. | Alignment and connection systems and methods |
US20110178461A1 (en) * | 2009-09-02 | 2011-07-21 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20130113506A1 (en) * | 2010-04-08 | 2013-05-09 | Disney Enterprises, Inc. | System and method for sensing human activity by monitoring impedance |
CN103520797A (en) * | 2013-11-04 | 2014-01-22 | 李秀 | Closed-loop drug releasing system |
EP2719411A1 (en) * | 2012-10-09 | 2014-04-16 | Becton, Dickinson and Company | Infusion site leak detection device |
US20140121598A1 (en) * | 2012-10-30 | 2014-05-01 | Seiko Epson Corporation | Liquid transport apparatus and catheter coming-off determination method |
CN104043159A (en) * | 2013-03-14 | 2014-09-17 | 精工爱普生株式会社 | Liquid Transporting Apparatus And Liquid Transporting Method |
US9039653B2 (en) | 2009-12-29 | 2015-05-26 | Medtronic Minimed, Inc. | Retention systems and methods |
US20150238708A1 (en) * | 2012-09-11 | 2015-08-27 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device with needle alignment detection mechanism |
US9347901B2 (en) | 2012-10-30 | 2016-05-24 | Seiko Epson Corporation | Liquid transport apparatus and bubble determination method |
US9421321B2 (en) | 2009-12-30 | 2016-08-23 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9518813B2 (en) | 2009-12-30 | 2016-12-13 | Medtronic Minimed, Inc. | Sensing systems and methods |
US9610405B2 (en) | 2009-12-30 | 2017-04-04 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US20170100534A1 (en) * | 2014-03-27 | 2017-04-13 | Nemoto Kyorindo Co., Ltd. | Sensor pad kit for leak detection sensor, leak detection system, and chemical liquid injection system |
JP2019504710A (en) * | 2016-02-12 | 2019-02-21 | ペルキュフロー, エルエルシー | Portable infusion pump and assembly for use with it |
US10946137B2 (en) | 2014-09-30 | 2021-03-16 | Medtronic Minimed, Inc. | Hybrid ambulatory infusion pumps |
US10967124B2 (en) | 2010-11-20 | 2021-04-06 | Medtronic Minimed, Inc. | Infusion pumps |
US11260171B2 (en) | 2017-07-04 | 2022-03-01 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and assemblies for use with same |
US11452473B2 (en) * | 2019-02-12 | 2022-09-27 | Johnson Medtech Llc | Medical device with capacitive sensing function |
US11497850B2 (en) | 2009-12-30 | 2022-11-15 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US11547792B2 (en) | 2010-09-24 | 2023-01-10 | Medtronic Minimed, Inc. | Infusion pumps |
US11684712B2 (en) | 2015-02-18 | 2023-06-27 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and reservoir assemblies for use with same |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5176662A (en) * | 1990-08-23 | 1993-01-05 | Minimed Technologies, Ltd. | Subcutaneous injection set with improved cannula mounting arrangement |
US6416402B1 (en) * | 1998-08-25 | 2002-07-09 | Micron Technology, Inc. | Methods of polishing microelectronic substrates, and methods of polishing wafers |
US6461329B1 (en) * | 2000-03-13 | 2002-10-08 | Medtronic Minimed, Inc. | Infusion site leak detection system and method of using the same |
US20030007891A1 (en) * | 1999-08-20 | 2003-01-09 | Wilson Robert F. | Apparatus and method of detecting fluid |
US20040162521A1 (en) * | 2002-10-07 | 2004-08-19 | Henrik Bengtsson | Needle device comprising a plurality of needles |
US20040204673A1 (en) * | 2001-02-22 | 2004-10-14 | Flaherty J. Christopher | Modular infusion device and method |
US6830558B2 (en) * | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US20050065472A1 (en) * | 2003-07-22 | 2005-03-24 | Cindrich Chris N. | Patch-like infusion device |
US6960192B1 (en) * | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
US20060200020A1 (en) * | 2004-07-13 | 2006-09-07 | Mark Brister | Transcutaneous analyte sensor |
US20070049865A1 (en) * | 2003-08-01 | 2007-03-01 | Novo Nordisk A/S | Retraction means for transcutaneous device |
US20070073236A1 (en) * | 2005-09-26 | 2007-03-29 | Morten Mernoe | Dispensing fluid from an infusion pump system |
US20080051697A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
US20080051711A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080077081A1 (en) * | 2006-08-23 | 2008-03-27 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080269687A1 (en) * | 2007-04-30 | 2008-10-30 | Medtronic Minimed, Inc. | Adhesive Patch Systems and Methods |
US20080319414A1 (en) * | 2007-06-25 | 2008-12-25 | Medingo, Ltd. | Insertion device |
US20090054810A1 (en) * | 2003-03-24 | 2009-02-26 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US20090216194A1 (en) * | 2004-09-02 | 2009-08-27 | Elgaard Pedersen Per Erik | Medical Device Adapted for Detection of Drug Condition |
US20110166512A1 (en) * | 2008-09-10 | 2011-07-07 | Roche Diagnostics International Ag | Delivery device for use with a therapeutic drug |
US8152771B2 (en) * | 2001-09-27 | 2012-04-10 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
Family Cites Families (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1502811A (en) | 1919-09-30 | 1924-07-29 | High-frequency multiplex signaling system | |
US1505111A (en) | 1921-05-27 | 1924-08-19 | Original Odhner Ab | Recording weighing scale |
US2796308A (en) | 1955-11-08 | 1957-06-18 | Emil E Knittel | Power driven multiple revolving card files |
US3701345A (en) | 1970-09-29 | 1972-10-31 | Medrad Inc | Angiographic injector equipment |
US3884230A (en) | 1973-09-27 | 1975-05-20 | Goldwyn L Wulff | Flexible needle and guard device for a hypodermic syringe |
US3994295A (en) | 1975-08-22 | 1976-11-30 | Wulff Goldwyn L | Hypodermic syringe needle mounting |
US4429208A (en) | 1977-04-26 | 1984-01-31 | General Battery Corporation | Electrodes for use in the extrusion-fusion welding of lead parts through an aperture in a battery case |
CH636662A5 (en) | 1981-03-11 | 1983-06-15 | Martin Ullmann | ELASTIC TENSION GANG AND METHOD FOR MAKING THE SAME. |
JPS5848301U (en) | 1981-09-25 | 1983-04-01 | 動力炉・核燃料開発事業団 | cold trap |
DE3144825A1 (en) | 1981-11-11 | 1983-05-19 | Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg | Injection pump |
DE3215711A1 (en) | 1982-04-28 | 1983-11-10 | B. Braun Melsungen Ag, 3508 Melsungen | PRESSURE INFUSION APPARATUS FOR MEDICAL APPLICATIONS |
US4633232A (en) | 1984-03-30 | 1986-12-30 | Frederic P. Nelson | Alarm device |
DK159526C (en) | 1984-11-01 | 1991-04-08 | Novo Nordisk As | DRIVE MECHANISM FOR AXIAL PROMOTION OF A Piston Rod, Especially For An Injection Spray |
DE3739563C1 (en) | 1987-11-22 | 1989-04-13 | Fresenius Ag | Infusion syringe pump |
US5334188A (en) | 1987-12-07 | 1994-08-02 | Nissho Corporation | Connector with injection site |
US5122123A (en) | 1991-01-30 | 1992-06-16 | Vaillancourt Vincent L | Closed system connector assembly |
US5236416A (en) | 1991-05-23 | 1993-08-17 | Ivac Corporation | Syringe plunger position detection and alarm generation |
CA2129284C (en) | 1993-11-24 | 1999-03-09 | Kenneth J. Niehoff | Controlling plunger drives for fluid injection in animals |
US5533981A (en) | 1994-10-06 | 1996-07-09 | Baxter International Inc. | Syringe infusion pump having a syringe plunger sensor |
US5628309A (en) | 1996-01-25 | 1997-05-13 | Raya Systems, Inc. | Meter for electrically measuring and recording injection syringe doses |
US6607509B2 (en) | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US20070142776A9 (en) | 1997-02-05 | 2007-06-21 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US5880659A (en) | 1997-03-17 | 1999-03-09 | Woods; Randell | Magnetic switch assembly for detecting unauthorized opening of doors or windows |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
CA2484271C (en) | 1997-12-31 | 2007-04-24 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US5957895A (en) | 1998-02-20 | 1999-09-28 | Becton Dickinson And Company | Low-profile automatic injection device with self-emptying reservoir |
US5954697A (en) | 1998-03-02 | 1999-09-21 | Srisathapat; Chad | Threaded nut syringe plunger for use with a medication infusion pump |
JPH11339439A (en) | 1998-05-22 | 1999-12-10 | Sony Corp | Recording medium housing cassette |
US6743202B2 (en) | 1998-06-15 | 2004-06-01 | Medrad, Inc. | Encoding of syringe information |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6113068A (en) | 1998-10-05 | 2000-09-05 | Rymed Technologies | Swabbable needleless injection port system having low reflux |
US7766873B2 (en) | 1998-10-29 | 2010-08-03 | Medtronic Minimed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
US6645177B1 (en) | 1999-02-09 | 2003-11-11 | Alaris Medical Systems, Inc. | Directly engaged syringe driver system |
US6283943B1 (en) | 1999-02-19 | 2001-09-04 | Minimed Inc. | Negative pressure pump |
US6423035B1 (en) | 1999-06-18 | 2002-07-23 | Animas Corporation | Infusion pump with a sealed drive mechanism and improved method of occlusion detection |
US7395353B1 (en) | 1999-12-07 | 2008-07-01 | Telleo, Incorporated | Method and apparatus for processing internet site names through regular expression comparison |
US20010041869A1 (en) | 2000-03-23 | 2001-11-15 | Causey James D. | Control tabs for infusion devices and methods of using the same |
US6589229B1 (en) * | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
DE60128826T2 (en) | 2000-09-08 | 2008-02-07 | Insulet Corp., Beverly | Infusion device and system |
DK1695727T3 (en) | 2000-11-09 | 2008-12-01 | Insulet Corp | Device for transcutaneous administration |
US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US7323142B2 (en) | 2001-09-07 | 2008-01-29 | Medtronic Minimed, Inc. | Sensor substrate and method of fabricating same |
US6740072B2 (en) | 2001-09-07 | 2004-05-25 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US6770067B2 (en) | 2001-09-07 | 2004-08-03 | Medtronic Minimed, Inc. | Infusion device and driving mechanism for same |
US7018360B2 (en) | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
US7144384B2 (en) | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US7128727B2 (en) | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
US6932584B2 (en) | 2002-12-26 | 2005-08-23 | Medtronic Minimed, Inc. | Infusion device and driving mechanism and process for same with actuator for multiple infusion uses |
WO2005007223A2 (en) | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
US6727689B1 (en) | 2003-07-24 | 2004-04-27 | Honeywell International Inc. | Magnetic-effect sensing apparatus with signal thresholding |
US20050065760A1 (en) | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
US7731691B2 (en) | 2003-11-10 | 2010-06-08 | Smiths Medical Asd, Inc. | Subcutaneous infusion device and device for insertion of a cannula of an infusion device and method |
US6992478B2 (en) | 2003-12-22 | 2006-01-31 | Cts Corporation | Combination hall effect position sensor and switch |
MX2007002925A (en) | 2004-09-10 | 2007-08-14 | Becton Dickinson Co | Reconstituting infusion device. |
KR100692005B1 (en) | 2004-10-09 | 2007-03-09 | 엘지전자 주식회사 | Mobile station having photograph memo recording function and control method thereof |
US7507221B2 (en) | 2004-10-13 | 2009-03-24 | Mallinckrodt Inc. | Powerhead of a power injection system |
US7396051B2 (en) | 2005-01-14 | 2008-07-08 | Baxa Corporation | Swabable fluid connectors and fluid connector pairs |
US7641649B2 (en) | 2005-05-06 | 2010-01-05 | Medtronic Minimed, Inc. | Reservoir support and method for infusion device |
US7648491B2 (en) | 2005-05-13 | 2010-01-19 | Bob Rogers | Medical substance transfer system |
US20080197626A1 (en) | 2005-05-16 | 2008-08-21 | David Coambs | Coupling Device for Medical Lines |
EP1752172A1 (en) | 2005-08-12 | 2007-02-14 | F.Hoffmann-La Roche Ag | Drive mechanism for an infusionpump |
DE102005038497A1 (en) | 2005-08-13 | 2007-02-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Double chamber container without bypass |
US7713240B2 (en) | 2005-09-13 | 2010-05-11 | Medtronic Minimed, Inc. | Modular external infusion device |
US7935104B2 (en) | 2005-11-07 | 2011-05-03 | Medingo, Ltd. | Systems and methods for sustained medical infusion and devices related thereto |
PT1962926E (en) | 2005-12-23 | 2009-08-27 | Unomedical As | Injection device |
WO2007093981A2 (en) * | 2006-02-15 | 2007-08-23 | Medingo Ltd. | Systems and methods for sensing analyte and dispensing therapeutic fluid |
US7871399B2 (en) | 2006-05-17 | 2011-01-18 | Alcon Research, Ltd. | Disposable ophthalmic injection device |
US7828764B2 (en) | 2006-08-23 | 2010-11-09 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7789857B2 (en) | 2006-08-23 | 2010-09-07 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US7794434B2 (en) | 2006-08-23 | 2010-09-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
CN105327418B (en) | 2006-12-22 | 2022-04-26 | F·霍夫曼-拉罗氏股份公司 | System and device for sustained delivery of therapeutic fluid |
CA2676811A1 (en) | 2007-02-02 | 2008-08-07 | Unomedical A/S | Injection site for injecting medication |
EP2150297A1 (en) | 2007-04-30 | 2010-02-10 | Medtronic MiniMed, Inc. | Needle inserting and fluid flow connection for infusion medium delivery system |
US7931621B2 (en) | 2007-05-11 | 2011-04-26 | Calibra Medical, Inc. | Infusion assembly |
US20080319394A1 (en) | 2007-06-11 | 2008-12-25 | Medingo, Ltd. | Portable infusion device with reduced level of operational noise |
WO2009016638A1 (en) | 2007-08-01 | 2009-02-05 | Medingo Ltd. | Device for facilitating infusion of therapeutic fluids and sensing of bodily analytes |
US8147446B2 (en) | 2007-08-01 | 2012-04-03 | Medingo Ltd. | Detachable portable infusion device |
US8303545B2 (en) | 2007-09-07 | 2012-11-06 | Stat Medical Devices, Inc. | Infusion device and method of using and making the same |
WO2009066288A1 (en) * | 2007-11-21 | 2009-05-28 | Medingo Ltd. | Analyte monitoring and fluid dispensing system |
US7875022B2 (en) | 2007-12-12 | 2011-01-25 | Asante Solutions, Inc. | Portable infusion pump and media player |
JP2009195669A (en) | 2008-01-25 | 2009-09-03 | Canon Inc | Medicine ejection apparatus and control method thereof |
CN101970033A (en) | 2008-02-08 | 2011-02-09 | 优诺医疗有限公司 | Assembly comprising inserter, cannula part and base part |
CA2715144A1 (en) | 2008-02-25 | 2009-09-03 | Unomedical A/S | Bubble shaped membrane and use of such membrane in a device |
KR20090106755A (en) | 2008-04-07 | 2009-10-12 | 주식회사 케이티테크 | Method, Terminal for providing memo recording function and computer readable record-medium on which program for executing method thereof |
DK3260145T3 (en) | 2008-04-09 | 2020-02-17 | Hoffmann La Roche | Fluid level sensor for a modular, skin adhesive medical fluid delivery system |
US9295776B2 (en) | 2008-04-11 | 2016-03-29 | Medtronic Minimed, Inc. | Reservoir plunger head systems and methods |
US8858501B2 (en) | 2008-04-11 | 2014-10-14 | Medtronic Minimed, Inc. | Reservoir barrier layer systems and methods |
ATE538825T1 (en) | 2008-05-07 | 2012-01-15 | Hoffmann La Roche | DISPLAY FOR AN INFUSION DELIVERY SYSTEM |
EP2303359B1 (en) | 2008-05-29 | 2020-02-26 | Roche Diabetes Care GmbH | Modular medical infusion device with means for identification/authentication between its components |
US9275684B2 (en) | 2008-09-12 | 2016-03-01 | At&T Intellectual Property I, L.P. | Providing sketch annotations with multimedia programs |
EP2370126A2 (en) | 2008-10-10 | 2011-10-05 | DEKA Products Limited Partnership | Infusion pump assemble |
US9370621B2 (en) | 2008-12-16 | 2016-06-21 | Medtronic Minimed, Inc. | Needle insertion systems and methods |
US8002748B2 (en) | 2009-04-24 | 2011-08-23 | Kyphon Sarl | Digital syringe with compensation control |
US8269797B2 (en) | 2009-08-03 | 2012-09-18 | Ricoh Company, Ltd. | Appropriately scaled map display with superposed information |
US8308679B2 (en) | 2009-12-30 | 2012-11-13 | Medtronic Minimed, Inc. | Alignment systems and methods |
US8932256B2 (en) | 2009-09-02 | 2015-01-13 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US8900190B2 (en) | 2009-09-02 | 2014-12-02 | Medtronic Minimed, Inc. | Insertion device systems and methods |
KR20110064082A (en) | 2009-12-07 | 2011-06-15 | 삼성전자주식회사 | Method for providing function to write text and function to scrap, and electronic apparatus |
US9039653B2 (en) | 2009-12-29 | 2015-05-26 | Medtronic Minimed, Inc. | Retention systems and methods |
US8998858B2 (en) | 2009-12-29 | 2015-04-07 | Medtronic Minimed, Inc. | Alignment and connection systems and methods |
US8998840B2 (en) | 2009-12-30 | 2015-04-07 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US8858500B2 (en) | 2009-12-30 | 2014-10-14 | Medtronic Minimed, Inc. | Engagement and sensing systems and methods |
US9421321B2 (en) * | 2009-12-30 | 2016-08-23 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US20120215163A1 (en) | 2009-12-30 | 2012-08-23 | Medtronic Minimed, Inc. | Sensing systems and methods |
US8435209B2 (en) | 2009-12-30 | 2013-05-07 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US8377002B2 (en) * | 2010-03-24 | 2013-02-19 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9973808B2 (en) | 2015-01-05 | 2018-05-15 | The Directv Group, Inc. | Streamlined viewing of recorded programs based on markers |
US10226104B2 (en) | 2015-08-19 | 2019-03-12 | Nike, Inc. | Cord lock |
KR102649348B1 (en) | 2018-10-29 | 2024-03-20 | 삼성전자주식회사 | Gas sensing device, electronic device including the same, and gas sensing system |
US11175108B1 (en) | 2020-06-17 | 2021-11-16 | Strike Industries, Inc. | Modular bolt catch for firearms |
-
2012
- 2012-05-02 US US13/462,752 patent/US20120215163A1/en not_active Abandoned
- 2012-11-09 WO PCT/US2012/064454 patent/WO2013074418A2/en active Application Filing
-
2013
- 2013-05-22 US US13/900,463 patent/US9518813B2/en active Active
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5176662A (en) * | 1990-08-23 | 1993-01-05 | Minimed Technologies, Ltd. | Subcutaneous injection set with improved cannula mounting arrangement |
US6416402B1 (en) * | 1998-08-25 | 2002-07-09 | Micron Technology, Inc. | Methods of polishing microelectronic substrates, and methods of polishing wafers |
US20030007891A1 (en) * | 1999-08-20 | 2003-01-09 | Wilson Robert F. | Apparatus and method of detecting fluid |
US6461329B1 (en) * | 2000-03-13 | 2002-10-08 | Medtronic Minimed, Inc. | Infusion site leak detection system and method of using the same |
US20040204673A1 (en) * | 2001-02-22 | 2004-10-14 | Flaherty J. Christopher | Modular infusion device and method |
US8152771B2 (en) * | 2001-09-27 | 2012-04-10 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
US6830558B2 (en) * | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6960192B1 (en) * | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
US20040162521A1 (en) * | 2002-10-07 | 2004-08-19 | Henrik Bengtsson | Needle device comprising a plurality of needles |
US20090054810A1 (en) * | 2003-03-24 | 2009-02-26 | Intuity Medical, Inc. | Analyte concentration detection devices and methods |
US20050065472A1 (en) * | 2003-07-22 | 2005-03-24 | Cindrich Chris N. | Patch-like infusion device |
US20070049865A1 (en) * | 2003-08-01 | 2007-03-01 | Novo Nordisk A/S | Retraction means for transcutaneous device |
US20060200020A1 (en) * | 2004-07-13 | 2006-09-07 | Mark Brister | Transcutaneous analyte sensor |
US20090216194A1 (en) * | 2004-09-02 | 2009-08-27 | Elgaard Pedersen Per Erik | Medical Device Adapted for Detection of Drug Condition |
US20070073236A1 (en) * | 2005-09-26 | 2007-03-29 | Morten Mernoe | Dispensing fluid from an infusion pump system |
US20080051697A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
US20080051711A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080077081A1 (en) * | 2006-08-23 | 2008-03-27 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080269687A1 (en) * | 2007-04-30 | 2008-10-30 | Medtronic Minimed, Inc. | Adhesive Patch Systems and Methods |
US20080319414A1 (en) * | 2007-06-25 | 2008-12-25 | Medingo, Ltd. | Insertion device |
US20110166512A1 (en) * | 2008-09-10 | 2011-07-07 | Roche Diagnostics International Ag | Delivery device for use with a therapeutic drug |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932256B2 (en) | 2009-09-02 | 2015-01-13 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20110054400A1 (en) * | 2009-09-02 | 2011-03-03 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US11638593B2 (en) | 2009-09-02 | 2023-05-02 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US8882710B2 (en) | 2009-09-02 | 2014-11-11 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20110178461A1 (en) * | 2009-09-02 | 2011-07-21 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US10675055B2 (en) | 2009-09-02 | 2020-06-09 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20110054399A1 (en) * | 2009-09-02 | 2011-03-03 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US9943332B2 (en) | 2009-09-02 | 2018-04-17 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US9393363B2 (en) | 2009-09-02 | 2016-07-19 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US8900190B2 (en) | 2009-09-02 | 2014-12-02 | Medtronic Minimed, Inc. | Insertion device systems and methods |
US20110160678A1 (en) * | 2009-12-29 | 2011-06-30 | Medtronic Minimed, Inc. | Alignment and connection systems and methods |
US8998858B2 (en) | 2009-12-29 | 2015-04-07 | Medtronic Minimed, Inc. | Alignment and connection systems and methods |
US9039653B2 (en) | 2009-12-29 | 2015-05-26 | Medtronic Minimed, Inc. | Retention systems and methods |
US10350353B2 (en) * | 2009-12-30 | 2019-07-16 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US9421321B2 (en) | 2009-12-30 | 2016-08-23 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US20110160655A1 (en) * | 2009-12-30 | 2011-06-30 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US20170157322A1 (en) * | 2009-12-30 | 2017-06-08 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US11497850B2 (en) | 2009-12-30 | 2022-11-15 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US8998840B2 (en) | 2009-12-30 | 2015-04-07 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9610405B2 (en) | 2009-12-30 | 2017-04-04 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US20120172803A1 (en) * | 2009-12-30 | 2012-07-05 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9039659B2 (en) * | 2009-12-30 | 2015-05-26 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9545474B2 (en) | 2009-12-30 | 2017-01-17 | Medtronic Minimed, Inc. | Connection and alignment systems and methods |
US9518813B2 (en) | 2009-12-30 | 2016-12-13 | Medtronic Minimed, Inc. | Sensing systems and methods |
US20170157321A1 (en) * | 2009-12-30 | 2017-06-08 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US10322233B2 (en) * | 2009-12-30 | 2019-06-18 | Medtronic Minimed, Inc. | Connection and alignment detection systems and methods |
US9366706B2 (en) * | 2010-04-08 | 2016-06-14 | Disney Enterprises, Inc. | System and method for sensing human activity by monitoring impedance |
US20130113506A1 (en) * | 2010-04-08 | 2013-05-09 | Disney Enterprises, Inc. | System and method for sensing human activity by monitoring impedance |
US11547792B2 (en) | 2010-09-24 | 2023-01-10 | Medtronic Minimed, Inc. | Infusion pumps |
US10967124B2 (en) | 2010-11-20 | 2021-04-06 | Medtronic Minimed, Inc. | Infusion pumps |
US20150238708A1 (en) * | 2012-09-11 | 2015-08-27 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device with needle alignment detection mechanism |
US9861766B2 (en) * | 2012-09-11 | 2018-01-09 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device with needle alignment detection mechanism |
US10773020B2 (en) | 2012-10-09 | 2020-09-15 | Becton, Dickinson And Company | Infusion site leak detection device |
EP2719411A1 (en) * | 2012-10-09 | 2014-04-16 | Becton, Dickinson and Company | Infusion site leak detection device |
US9750876B2 (en) | 2012-10-09 | 2017-09-05 | Becton, Dickinson And Company | Infusion site leak detection device |
CN103785075A (en) * | 2012-10-30 | 2014-05-14 | 精工爱普生株式会社 | Liquid transport apparatus and catheter coming-off determination method |
US9347901B2 (en) | 2012-10-30 | 2016-05-24 | Seiko Epson Corporation | Liquid transport apparatus and bubble determination method |
US20140121598A1 (en) * | 2012-10-30 | 2014-05-01 | Seiko Epson Corporation | Liquid transport apparatus and catheter coming-off determination method |
JP2014087449A (en) * | 2012-10-30 | 2014-05-15 | Seiko Epson Corp | Liquid transport device and method for determining catheter drop-out |
US20140276380A1 (en) * | 2013-03-14 | 2014-09-18 | Seiko Epson Corporation | Liquid transporting apparatus and liquid transporting method |
CN104043159A (en) * | 2013-03-14 | 2014-09-17 | 精工爱普生株式会社 | Liquid Transporting Apparatus And Liquid Transporting Method |
JP2014176455A (en) * | 2013-03-14 | 2014-09-25 | Seiko Epson Corp | Liquid transport apparatus and liquid transport method |
CN103520797A (en) * | 2013-11-04 | 2014-01-22 | 李秀 | Closed-loop drug releasing system |
US10342915B2 (en) * | 2014-03-27 | 2019-07-09 | Nemoto Kyorindo Co., Ltd. | Sensor pad kit for leak detection sensor, leak detection system, and chemical liquid injection system |
US20170100534A1 (en) * | 2014-03-27 | 2017-04-13 | Nemoto Kyorindo Co., Ltd. | Sensor pad kit for leak detection sensor, leak detection system, and chemical liquid injection system |
US10946137B2 (en) | 2014-09-30 | 2021-03-16 | Medtronic Minimed, Inc. | Hybrid ambulatory infusion pumps |
US11684712B2 (en) | 2015-02-18 | 2023-06-27 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and reservoir assemblies for use with same |
JP7069023B2 (en) | 2016-02-12 | 2022-05-17 | メドトロニック ミニメド インコーポレイテッド | Carrying injection pump and assembly for use with it |
US10940264B2 (en) | 2016-02-12 | 2021-03-09 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and assemblies for use with same |
JP2019504710A (en) * | 2016-02-12 | 2019-02-21 | ペルキュフロー, エルエルシー | Portable infusion pump and assembly for use with it |
US11672909B2 (en) | 2016-02-12 | 2023-06-13 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and assemblies for use with same |
US11260171B2 (en) | 2017-07-04 | 2022-03-01 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and assemblies for use with same |
US11452473B2 (en) * | 2019-02-12 | 2022-09-27 | Johnson Medtech Llc | Medical device with capacitive sensing function |
Also Published As
Publication number | Publication date |
---|---|
WO2013074418A2 (en) | 2013-05-23 |
WO2013074418A3 (en) | 2013-08-01 |
US9518813B2 (en) | 2016-12-13 |
US20130253422A1 (en) | 2013-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9518813B2 (en) | Sensing systems and methods | |
US11638593B2 (en) | Insertion device systems and methods | |
US9421321B2 (en) | Connection and alignment systems and methods | |
US9545474B2 (en) | Connection and alignment systems and methods | |
US10322233B2 (en) | Connection and alignment detection systems and methods | |
US8308679B2 (en) | Alignment systems and methods | |
US8377002B2 (en) | Connection and alignment systems and methods | |
US20230069487A1 (en) | Connection and alignment detection systems and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HANSON, IAN B.;BENTE, IV, PAUL F.;SIGNING DATES FROM 20120405 TO 20120411;REEL/FRAME:028149/0517 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |